# CNO Financial Group, Inc.: Form 10-Q for the period ended Jun 30, 2020

- Company: [CNO Financial Group, Inc.](/companies/cno.md) (CIK 1224608)
- Form: 10-Q
- Filed: 2020-08-07
- Accepted by EDGAR: Aug 7, 2020, 15:41 ET
- Period: 2020-06-30
- Accession: 0001224608-20-000032
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1224608/000122460820000032/cno0630202010-q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1224608/000122460820000032/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-04-01 to 2020-06-30 | $1.01bn | us-gaap:Revenues |
| Revenue | 6 months, 2020-01-01 to 2020-06-30 | $1.73bn | us-gaap:Revenues |
| Operating income | 3 months, 2020-04-01 to 2020-06-30 | $102.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2020-01-01 to 2020-06-30 | $207.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2020-04-01 to 2020-06-30 | $28.4m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2020-01-01 to 2020-06-30 | $61.8m | us-gaap:InterestExpense |
| Income tax | 3 months, 2020-04-01 to 2020-06-30 | $23.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2020-01-01 to 2020-06-30 | $7.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-04-01 to 2020-06-30 | $82.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2020-01-01 to 2020-06-30 | $60.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-04-01 to 2020-06-30 | $0.57 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2020-01-01 to 2020-06-30 | $0.42 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-04-01 to 2020-06-30 | $0.57 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2020-01-01 to 2020-06-30 | $0.42 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-04-01 to 2020-06-30 | 143,941,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2020-01-01 to 2020-06-30 | 145,269,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2020-01-01 to 2020-06-30 | $325.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 6 months, 2020-01-01 to 2020-06-30 | $33.6m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months, 2020-01-01 to 2020-06-30 | $118.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Total assets | at 2020-06-30 | $33.98bn | us-gaap:Assets |
| Total liabilities | at 2020-06-30 | $29.25bn | us-gaap:Liabilities |
| Long-term debt | at 2020-06-30 | $1.00bn | us-gaap:LongTermDebt |
| Shareholders' equity | at 2020-06-30 | $4.73bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 111,062 characters.

In this section, we review the consolidated financial condition of CNO at June 30, 2020, and its consolidated results of operations for the six months ended June 30, 2020 and 2019, and, where appropriate, factors that may affect future financial performance. Please read this discussion in conjunction with the accompanying consolidated financial statements and notes. Results for interim periods are not necessarily indicative of the results that may be expected for a full year, especially when considering the risks and uncertainties associated with the COVID-19 pandemic and the impact it may have on our business, results of operations and financial condition. For additional forward-looking information and risks related to the impact of the pandemic refer to Liquidity and Capital Resources - Potential Impacts of COVID-19 Pandemic included in Management's Discussion and Analysis of Financial Condition and Results of Operations and Item 1A - Risk Factors. In addition, the results for the quarterly period ended June 30, 2020, were impacted by: (i) our actuarial unlocking exercise to reduce future expected new money rates and lower the option budgets on our fixed index products; and (ii) increase our accrual for the Global Resolution Agreement.

We are closely monitoring developments relating to COVID-19 and assessing its impact on our business, policyholders, agents and associates. Depending on the duration and severity of the pandemic, we foresee the potential for some adverse impacts related to, among other things, near-term sales results, insurance product margin, net investment income, invested assets, regulatory capital, liabilities for insurance products, deferred acquisition costs, the present value of future profits, and income tax assets, although the full extent to which COVID-19 impacts financial results remains uncertain.

Operationally, we implemented our business continuity plans and took other precautions, such as employee business travel restrictions and remote work arrangements which, to date, have enabled us to support the health and wellness of our agents and associates, while maintaining our critical business processes, customer service levels, relationships with key vendors, financial reporting systems, internal controls over financial reporting and disclosure controls and procedures. In addition, we implemented additional cybersecurity precautions as a result of our remote working environment. We also introduced financial support programs for our exclusive agents who have seen their businesses disrupted, and their livelihoods challenged, and we deployed enhanced technology tools and training for such agents to allow them to serve consumers through virtual consultations and digital insurance applications.

While we have implemented risk management and contingency plans and taken other precautions with respect to the COVID-19 pandemic, such measures may not adequately protect our business from the full impacts of the pandemic. Currently, most of our employees are working remotely with only a few operationally critical employees working at certain of our facilities for business continuity purposes. An extended period of remote work arrangements could strain our business continuity plans, introduce additional operational risk, including but not limited to cybersecurity risks, and impair our ability to effectively manage our business.

In addition, the pandemic and its impact on the economy and financial markets could materially adversely affect our business, results of operations, investment portfolio or financial condition. We will continue reviewing accounting estimates, asset valuations and various financial scenarios for capital and liquidity; however, in light of evolving health, economic, governmental, social, and other factors, the potential impact of COVID-19 and actions taken in response to it on our business, results of operations, investment portfolio and financial condition remains uncertain.

### CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

Our statements, trend analyses and other information contained in this report and elsewhere (such as in filings by CNO with the SEC, press releases, presentations by CNO or its management or oral statements) relative to markets for CNO's products and trends in CNO's operations or financial results, as well as other statements, contain forward-looking statements within the meaning of the federal securities laws and the Private Securities Litigation Reform Act of 1995. Forward-looking statements typically are identified by the use of terms such as "anticipate," "believe," "plan," "estimate," "expect," "project," "intend," "may," "will," "would," "contemplate," "possible," "attempt," "seek," "should," "could," "goal," "target," "on track," "comfortable with," "optimistic," "guidance," "outlook" and similar words, although some forward-looking statements are expressed differently. You should consider statements that contain these words carefully because they describe our expectations, plans, strategies and goals and our beliefs concerning future business conditions, our results of operations, financial position, and our business outlook or they state other "forward-looking" information based on currently available information. The "Risk Factors" section of our 2019 Annual Report on Form 10-K and the changes set forth in the Risk Factors section of this Form 10-Q provide examples of risks, uncertainties and events that could cause our actual results to differ materially from the expectations expressed in our forward-looking statements. Assumptions and other important factors that could cause our actual results to differ materially from those anticipated in our forward-looking statements include, among other things:

- the ongoing COVID-19 pandemic and the resulting financial market, economic and other impacts could adversely affect our business, results of operations, financial condition and liquidity;
- changes in or sustained low interest rates causing reductions in investment income, the margins of our fixed annuity and life insurance businesses, and sales of, and demand for, our products;
- expectations of lower future investment earnings may cause us to accelerate amortization, write down the balance of insurance acquisition costs or establish additional liabilities for insurance products;
- general economic, market and political conditions and uncertainties, including the performance and fluctuations of the financial markets which may affect the value of our investments as well as our ability to raise capital or refinance existing indebtedness and the cost of doing so;
- the ultimate outcome of lawsuits filed against us and other legal and regulatory proceedings to which we are subject;
- our ability to make anticipated changes to certain non-guaranteed elements of our life insurance products;
- our ability to obtain adequate and timely rate increases on our health products, including our long-term care business;
- the receipt of any required regulatory approvals for dividend and surplus debenture interest payments from our insurance subsidiaries;
- mortality, morbidity, the increased cost and usage of health care services, persistency, the adequacy of our previous reserve estimates, changes in the health care market and other factors which may affect the profitability of our insurance products;
- changes in our assumptions related to deferred acquisition costs or the present value of future profits;
- the recoverability of our deferred tax assets and the effect of potential ownership changes and tax rate changes on their value;
- our assumption that the positions we take on our tax return filings will not be successfully challenged by the Internal Revenue Service;
- changes in accounting principles and the interpretation thereof;
- our ability to continue to satisfy the financial ratio and balance requirements and other covenants of our debt agreements;
- our ability to achieve anticipated expense reductions and levels of operational efficiencies including improvements in claims adjudication and continued automation and rationalization of operating systems;
- performance and valuation of our investments, including the impact of realized losses (including other-than-temporary impairment charges);
- our ability to identify products and markets in which we can compete effectively against competitors with greater market share, higher ratings, greater financial resources and stronger brand recognition;
- our ability to generate sufficient liquidity to meet our debt service obligations and other cash needs;
- changes in capital deployment opportunities;
- our ability to maintain effective controls over financial reporting;
- our ability to continue to recruit and retain productive agents and distribution partners;
- customer response to new products, distribution channels and marketing initiatives;
- our ability to maintain the financial strength ratings of CNO and our insurance company subsidiaries as well as the impact of our ratings on our business, our ability to access capital, and the cost of capital;
- regulatory changes or actions, including: those relating to regulation of the financial affairs of our insurance companies, such as the calculation of risk-based capital and minimum capital requirements, and payment of dividends and surplus debenture interest to us; regulation of the sale, underwriting and pricing of products; and health care regulation affecting health insurance products;
- changes in the Federal income tax laws and regulations which may affect or eliminate the relative tax advantages of some of our products or affect the value of our deferred tax assets;
- availability and effectiveness of reinsurance arrangements, as well as the impact of any defaults or failure of reinsurers to perform;
- the performance of third party service providers and potential difficulties arising from outsourcing arrangements;
- the growth rate of sales, collected premiums, annuity deposits and assets;
- interruption in telecommunication, information technology or other operational systems or failure to maintain the security, confidentiality or privacy of sensitive data on such systems;
- events of terrorism, cyber attacks, natural disasters or other catastrophic events, including losses from a disease pandemic or potential adverse impacts from global warming;
- ineffectiveness of risk management policies and procedures in identifying, monitoring and managing risks; and
- the risk factors or uncertainties listed from time to time in our filings with the SEC.

Other factors and assumptions not identified above are also relevant to the forward-looking statements, and if they prove incorrect, could also cause actual results to differ materially from those projected.

All written or oral forward-looking statements attributable to us are expressly qualified in their entirety by the foregoing cautionary statement. Our forward-looking statements speak only as of the date made. We assume no obligation to update or to publicly announce the results of any revisions to any of the forward-looking statements to reflect actual results, future events or developments, changes in assumptions or changes in other factors affecting the forward-looking statements.

The reporting of risk-based capital ("RBC") measures is not intended for the purpose of ranking any insurance company or for use in connection with any marketing, advertising or promotional activities.

### OVERVIEW

We are a holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance products. We focus on serving the senior and middle-income markets, which we believe are attractive, underserved, high growth markets. We sell our products through three distribution channels: career agents, independent producers (some of whom sell one or more of our product lines exclusively) and direct marketing.

Prior to 2020, the Company managed its business through the following operating segments: Bankers Life, Washington National and Colonial Penn, which were defined on the basis of product distribution; long-term care in run-off; and corporate operations, comprised of holding company activities and certain noninsurance company businesses.

In January 2020, we announced a new operating model that changes how we view our operating segments. Instead of the operating business segments described above, we view our operations as four insurance product lines (annuity, health, life and long-term care) and the investment and fee revenue segments. The new structure creates a leaner, more integrated, customer-centric organization that better positions us for long-term success and shareholder value creation. Our new segments are aligned based on their common characteristics, comparability of profit margins and the way management makes operating decisions and assesses the performance of the business. We began reporting under the new segment structure in the first quarter of 2020. Prior period results have been reclassified to conform to the new reporting structure.

Our insurance product line segments (including annuity, health, life and long-term care) include marketing, underwriting and administration of the policies our insurance subsidiaries sell. Under our new operating model, the business written in each of the four product categories through all of our insurance subsidiaries is aggregated allowing management and investors to assess the performance of each product category. When analyzing profitability of these segments, we use insurance product margin as the measure of profitability, which is: (i) insurance policy income; and (ii) net investment income allocated to the insurance product lines; less (i) insurance policy benefits and interest credited to policyholders; and (ii) amortization, non-deferred commissions and advertising expense. Net investment income is allocated to the product lines using the book yield of investments backing the block of business, which is applied to the average insurance liabilities, net of insurance intangibles, for the block in each period.

Income from insurance products is the sum of the insurance margins of the annuity, health, life and long-term care product lines, less expenses allocated to the insurance lines. It excludes the income from our fee income business, investment income not allocated to product lines, net expenses not allocated to product lines (primarily holding company expenses) and income taxes. Management believes insurance product margin and income from insurance products help provide a better understanding of the business and a more meaningful analysis of the results of our insurance product lines.

Under our new structure, we market our insurance products through the Consumer and Worksite Divisions that reflect the customers served by the Company.

The Consumer Division serves individual consumers, engaging with them on the phone, online, face-to-face with agents, or through a combination of sales channels. This structure unifies consumer capabilities into a single division and integrates the strength of our agent sales forces and industry-leading direct-to-consumer business with proven experience in advertising, web/digital and call center support.

The Worksite Division focuses on worksite and group sales for businesses, associations, and other membership groups, interacting with customers at their place of employment. By creating a dedicated Worksite Division, we bring a sharper focus to this high-growth business while further capitalizing on the strength of our recent acquisition of WBD. The individual results for the Worksite Division are currently not significant pursuant to accounting standards. Sales in the Worksite Division have been particularly adversely impacted by the COVID-19 pandemic given the challenges of interacting with customers at their place of employment. We plan to analyze the profitability of the insurance products of the Consumer and Worksite Divisions separately when the Worksite Division becomes significant.

We also centralized certain functional areas previously housed in the three business segments, including marketing, business unit finance, sales training and support, and agent recruiting, among others. All policy, contract, and certificate terms, conditions, and benefits remain unchanged.

The investment segment involves the management of our capital resources, including investments and the management of corporate debt and liquidity. Our measure of profitability of this segment is the total net investment income not allocated to the insurance products. Investment income not allocated to product lines represents net investment income less: (i) equity returns credited to policyholder account balances; (ii) the investment income allocated to our product lines; (iii) interest expense on notes payable and investment borrowings; and (iv) certain expenses related to benefit plans that are offset by special-purpose investment income. Investment income not allocated to product lines includes investment income on investments in excess of average insurance liabilities, investments held by our holding companies, the spread we earn from the FHLB investment borrowing program and variable components of investment income (including call and prepayment income, adjustments to returns on structured securities due to cash flow changes, income (loss) from COLI and variations in income (loss) from alternative investments), net of interest expense on corporate debt.

Our fee and other revenue segment includes the earnings generated from sales of third-party insurance products, services provided by WBD (our wholly owned on-line benefit administration firm) and the operations of our broker-dealer and registered investment advisor.

Expenses not allocated to product lines include the expenses of our corporate operations, excluding interest expense on debt.

The following summarizes our earnings for the three and six months ending June 30, 2020 and 2019 (dollars in millions, except per share data):

| Insurance product margin | Three months ended June 30, 2020 | 2019 | Six months ended June 30, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| Annuity margin | $123.8 | $57.2 | $183.3 | $113.4 |
| Health margin | 82.3 | 78.3 | 155.9 | 157.2 |
| Life margin | 36.1 | 51.7 | 80.4 | 94.8 |
| Long-term care margin | 13.2 | 11.9 | 26.5 | 23.4 |
| Total insurance product margin | 255.4 | 199.1 | 446.1 | 388.8 |
| Allocated expenses | (128.1) | (135.2) | (264.7) | (271.1) |
| Income from insurance products | 127.3 | 63.9 | 181.4 | 117.7 |
| Fee income | 5.2 | 4.4 | 13.0 | 8.8 |
| Investment income not allocated to product lines | 8.2 | 48.3 | 65.6 | 91.6 |
| Expenses not allocated to product lines | (38.5) | (19.9) | (52.3) | (38.0) |
| Operating earnings before taxes | 102.2 | 96.7 | 207.7 | 180.1 |
| Income tax expense on operating income | (22.8) | (20.3) | (44.0) | (37.9) |
| Net operating income (a) | 79.4 | 76.4 | 163.7 | 142.2 |
| Net realized investment gains (losses) from sales, impairments and change in allowance for credit losses (net of related amortization) | 12.3 | (1.7) | (51.4) | (2.4) |
| Net change in market value of investments recognized in earnings | 31.2 | 6.8 | (17.2) | 23.4 |
| Fair value changes related to agent deferred compensation plan | (13.2) | (11.6) | (13.2) | (16.9) |
| Fair value changes in embedded derivative liabilities (net of related amortization) | (27.1) | (35.9) | (93.8) | (65.5) |
| Loss on extinguishment of debt | — | (7.3) | — | (7.3) |
| Other | — | .7 | 2.3 | 1.9 |
| Net non-operating loss before taxes | 3.2 | (49.0) | (173.3) | (66.8) |
| Income tax benefit on non-operating loss | .6 | (10.2) | (36.4) | (14.0) |
| Valuation allowance for deferred tax assets and other tax items | — | — | (34.0) | — |
| Net non-operating loss | 2.6 | (38.8) | (102.9) | (52.8) |
| Net income | $82.0 | $37.6 | $60.8 | $89.4 |
| Per diluted share |  |  |  |  |
| Net operating income | $.55 | $.48 | $1.13 | $.89 |
| Net non-operating loss | .02 | (.24) | (.71) | (.33) |
| Net income | $.57 | $.24 | $.42 | $.56 |

59

(a) Management believes that an analysis of net operating income provides a clearer comparison of the operating results of the Company from period to period because it excludes: (i) net realized investment gains (losses) from sales, impairments and change in allowance for credit losses, net of related amortization and taxes; (ii) net change in market value of investments recognized in earnings, net of taxes; (iii) fair value changes due to fluctuations in the interest rates used to discount embedded derivative liabilities related to our fixed index annuities, net of related amortization and taxes; (iv) fair value changes related to the agent deferred compensation plan, net of taxes; (v) loss on extinguishment of debt, net of taxes; and (vi) other non-operating items consisting primarily of earnings attributable to VIEs. The table above reconciles the non-GAAP measures to the corresponding GAAP measure.

In addition, management uses these non-GAAP financial measures in its budgeting process, financial analysis of segment performance and in assessing the allocation of resources. We believe these non-GAAP financial measures enhance an investor’s understanding of our financial performance and allows them to make more informed judgments about the Company as a whole. These measures also highlight operating trends that might not otherwise be apparent. However, net operating income is not a measurement of financial performance under GAAP and should not be considered as an alternative to cash flow from operating activities, as a measure of liquidity, or as an alternative to net income as measures of our operating performance or any other measures of performance derived in accordance with GAAP. In addition, net operating income should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. Net operating income has limitations as an analytical tool, and you should not consider such measure either in isolation or as a substitute for analyzing our results as reported under GAAP. Our definition and calculation of net operating income are not necessarily comparable to other similarly titled measures used by other companies due to different methods of calculation.

### CRITICAL ACCOUNTING POLICIES

Refer to "Critical Accounting Policies" in our 2019 Annual Report on Form 10-K for information on our other accounting policies that we consider critical in preparing our consolidated financial statements.

### CHANGES IN ACTUARIAL ASSUMPTIONS IN THE SECOND QUARTER OF 2020

We conducted our annual comprehensive review of actuarial assumptions in the fourth quarter of 2019. However, we update our assumptions, as necessary, to the extent current conditions or circumstances warrant changes that could be significant to our operating results. Given our expectation that interest rates will remain low for the long-term, we performed an actuarial unlocking exercise in the second quarter of 2020 to reflect our assumption that average new money rates will remain flat at 4 percent for the long-term. This change and the related impacts to persistency assumptions had a $45.6 million unfavorable impact on pre-tax earnings. As part of the actuarial unlocking exercise, we also changed our assumptions related to the future option costs we incur in providing benefits on fixed index annuities which had a favorable impact on pre-tax earnings of $91.5 million. These future option costs represent the estimated cost we will incur to purchase a series of annual forward options over the duration of the policy that back the potential return based on a percentage of the amount of increase in the value of the appropriate index. When interest rates decrease, we are permitted (subject to policy minimums) to decrease this benefit, lowering the option costs. The impact of these changes in assumptions is summarized below (dollars in millions):

| Impacts of an average new money rate assumption of 4 percent | Line of business Fixed index annuities Favorable (unfavorable) | Fixed interest annuities | Interest- sensitive life | Total |
| --- | ---: | ---: | ---: | ---: |
| Insurance policy benefits | $(5.0) | $— | $(7.4) | $(12.4) |
| Amortization of insurance intangibles | (25.6) | (9.4) | 1.8 | (33.2) |
| Subtotal | (30.6) | (9.4) | (5.6) | (45.6) |
| Impacts of changes in future option costs |  |  |  |  |
| Insurance policy benefits | 104.8 | — | — | 104.8 |
| Amortization of insurance intangibles | (13.3) | — | — | (13.3) |
| Subtotal | 91.5 | — | — | 91.5 |
| Impact on pre-tax income | $60.9 | $(9.4) | $(5.6) | $45.9 |

As noted above, the magnitude of the offsetting impacts of the change in new money rate and the change in future option costs had significantly different impacts on our results in the second quarter of 2020. These results are consistent with the different accounting requirements for insurance intangibles and the embedded derivatives related to the future option budgets for our fixed index annuity products.

Insurance intangibles related to interest-sensitive products are amortized in relation to estimated gross profits using the interest rate credited to the underlying policies. When actual profits or our current best estimates of future profits are different than our previous estimates, we adjust the cumulative amortization of insurance acquisition costs to maintain amortization expense as a constant percentage of gross profits over the entire life of the policies.

Due to this accounting requirement, only a portion of the reduced estimated gross profits due to the change in new money rate assumptions is recognized in earnings in the period of unlocking. The adjustment to gross profits is spread on a retrospective basis over the life of the related blocks of business. The unlocking adjustment in the second quarter of 2020 is a “catch-up” adjustment recognized through earnings to reflect the inception date to current date income adjustments, as if our current assumptions were used to determine amortization from each policy’s inception date. For example, the changes in new money rate and persistency assumptions had the effect of reducing estimated gross profits by approximately $280 million. This impact compares to the net unfavorable unlocking adjustments of $45.6 million.

In contrast, the options attributable to the policyholder for the estimated life of the contract is treated as an embedded derivative. We are required to record the embedded derivatives related to our fixed index annuity products at estimated fair value. The value of the embedded derivatives is determined based on the present value of estimated future option costs discounted using a risk-free rate adjusted for our non-performance risk and a risk charge. This rate is currently very low at

.85%. Due to this accounting requirement, a significant percentage of the change in gross profits attributable to the change in option budgets is reflected in our current earnings as an unlocking adjustment. For example, the change in expected future option budgets had the effect of increasing estimated gross profits by approximately $105 million. This impact compares to the net favorable unlocking adjustments of $91.5 million.

Changes in future new money rate and persistency assumptions can also result in a charge related to our life, health and annuity with life contingency products. However, assumptions related to these products are locked in when the policies are issued and a charge is only taken when the present value of future cash flows, in combination with the related liability for insurance products, is less than the unamortized insurance intangible balance. In such case, the charge would be made to amortization expense at the time assumption changes result in a deficiency. If the deficiency exceeds the balance of insurance intangibles, a premium deficiency reserve is established for the excess. The recoverability test referred to above is conducted based on lines of business consistent with the manner we group them in our segment reporting.

Even after the changes in assumptions for new money rates, the loss recognition margins on our traditional life, long-term care, payout annuities, Medicare supplement and supplemental health products are positive. Although, no loss recognition is required in the second quarter of 2020, the future margins for these blocks would be reduced by approximately $160 million due to the impact of these changes in assumptions.

This actuarial unlocking exercise does not replace our comprehensive annual review of all assumptions for our insurance products, which we plan to complete in the fourth quarter of this year. Additional adjustments may be identified based on the results of the comprehensive annual review.

### RESULTS OF OPERATIONS

The following tables and narratives summarize the operating results of our segments (dollars in millions):

| Insurance product margin Annuity: | Three months ended June 30, 2020 | 2019 | Six months ended June 30, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| Insurance policy income | $4.5 | $4.2 | $10.1 | $10.8 |
| Net investment income | 116.6 | 114.8 | 234.0 | 230.6 |
| Insurance policy benefits | 107.7 | (5.1) | 102.2 | (13.0) |
| Interest credited | (43.6) | (41.6) | (85.6) | (84.8) |
| Amortization and non-deferred commissions | (61.4) | (15.1) | (77.4) | (30.2) |
| Annuity margin | 123.8 | 57.2 | 183.3 | 113.4 |
| Health: |  |  |  |  |
| Insurance policy income | 360.1 | 358.1 | 722.2 | 716.3 |
| Net investment income | 36.1 | 35.8 | 72.2 | 72.0 |
| Insurance policy benefits | (274.7) | (272.7) | (544.3) | (537.6) |
| Amortization and non-deferred commissions | (39.2) | (42.9) | (94.2) | (93.5) |
| Health margin | 82.3 | 78.3 | 155.9 | 157.2 |
| Life: |  |  |  |  |
| Insurance policy income | 194.3 | 189.0 | 388.4 | 376.2 |
| Net investment income | 34.7 | 34.8 | 69.0 | 69.3 |
| Insurance policy benefits | (147.8) | (126.2) | (279.7) | (257.0) |
| Interest credited | (10.9) | (10.6) | (21.2) | (20.8) |
| Amortization and non-deferred commissions | (18.0) | (20.3) | (39.9) | (41.2) |
| Advertising expense | (16.2) | (15.0) | (36.2) | (31.7) |
| Life margin | 36.1 | 51.7 | 80.4 | 94.8 |
| Long-term care: |  |  |  |  |
| Insurance policy income | 66.4 | 67.0 | 133.3 | 134.3 |
| Net investment income | 34.0 | 34.0 | 68.3 | 67.3 |
| Insurance policy benefits | (84.3) | (85.7) | (168.5) | (171.2) |
| Amortization and non-deferred commissions | (2.9) | (3.4) | (6.6) | (7.0) |
| Long-term care margin | 13.2 | 11.9 | 26.5 | 23.4 |
| Total insurance product margin | 255.4 | 199.1 | 446.1 | 388.8 |
| Allocated expenses: |  |  |  |  |
| Branch office expenses | (15.1) | (16.3) | (34.0) | (38.6) |
| Other allocated expenses | (113.0) | (118.9) | (230.7) | (232.5) |
| Income from insurance products | 127.3 | 63.9 | 181.4 | 117.7 |
| Fee income | 5.2 | 4.4 | 13.0 | 8.8 |
| Investment income not allocated to product lines | 8.2 | 48.3 | 65.6 | 91.6 |
| Expenses not allocated to product lines | (38.5) | (19.9) | (52.3) | (38.0) |
| Operating earnings before taxes | 102.2 | 96.7 | 207.7 | 180.1 |
| Income tax expense on operating income | (22.8) | (20.3) | (44.0) | (37.9) |
| Net operating income | $79.4 | $76.4 | $163.7 | $142.2 |

63

CNO is the top tier holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance products. We view our operations by segments, which consist of insurance product lines. These products are distributed by our two divisions. The Consumer Division serves individual consumers, engaging with them on the phone, online, face-to-face with agents, or through a combination of sales channels. The Worksite Division focuses on worksite and group sales for businesses, associations, and other membership groups, interacting with customers at their place of employment.

Insurance product margin is management’s measure of the profitability of its annuity, health, life and long-term care product lines’ performance and consists of premiums plus allocated investment income less insurance policy benefits, interest credited, commissions, advertising expense and amortization of acquisition costs. Income from insurance products is the sum of the insurance margins of the annuity, health, life and long-term care product lines, less expenses allocated to the insurance lines. It excludes the income from our fee income business, investment income not allocated to product lines, net expenses not allocated to product lines (primarily holding company expenses) and income taxes. Management believes insurance product margin and income from insurance products help provide a better understanding of the business and a more meaningful analysis of the results of our insurance product lines.

Investment income is allocated to the product lines using the book yield of investments backing the block of business, which is applied to the average insurance liabilities, net of insurance intangibles, for the block in each period. Investment income not allocated to product lines represents net investment income less the investment income allocated to our product lines and includes investment income on investments in excess of average insurance liabilities, investments held by our holding companies, the spread we earn from the FHLB investment borrowing program and variable components of investment income (including call and prepayment income, adjustments to returns on structured securities due to cash flow changes, income (loss) from COLI and variations in income (loss) from alternative investments), net of interest expense on corporate debt.

Management believes that an analysis of Net income applicable to common stock before: (i) net realized investment gains (losses) from sales, impairments and change in allowance for credit losses, net of related amortization and taxes; (ii) net change in market value of investments recognized in earnings, net of taxes; (iii) fair value changes due to fluctuations in the interest rates used to discount embedded derivative liabilities related to our fixed index annuities, net of related amortization and taxes; (iv) fair value changes related to the agent deferred compensation plan, net of taxes; (v) loss on extinguishment of debt, net of taxes; (vi) changes in the valuation allowance for deferred tax assets and other tax items; and (vii) other non-operating items consisting primarily of earnings attributable to VIEs, net of taxes (“Net operating income,” a non-GAAP financial measure) is important to evaluate the financial performance of the company, and is a key measure commonly used in the life insurance industry. Management uses this measure to evaluate performance because the items excluded from net operating income can be affected by events that are unrelated to the company's underlying fundamentals.

***Summary of Operating Results:*** Net operating income was $79.4 million in the second quarter of 2020, up from $76.4 million in the second quarter of 2019, and was $163.7 million in the first six months of 2020, up from $142.2 million in the first six months of 2019.

Insurance product margin for the three and six months ended June 30, 2020, was significantly impacted by changes in our actuarial assumptions as further described above under the caption "Changes in Actuarial Assumptions in the Second Quarter of 2020".

The higher fee income in the 2020 periods primarily reflects changes in assumptions used to estimate revenues on the sales of third-party products, net of related distribution expenses.

Investment income not allocated to product lines was lower in the 2020 periods as discussed in additional detail below.

Expenses not allocated to product lines were higher in the 2020 periods due to a $23.5 million increase (recognized in the second quarter of 2020) in our liability for claims and interest pursuant to the Global Resolution Agreement as the third-party auditor has provided information that we have processed and verified allowing us to more accurately estimate the ultimate liability pursuant to the agreement. See the note to the consolidated financial statements entitled "Litigation and Other Legal Proceedings - Regulatory Examinations and Fines" for further information about the Global Resolution Agreement.

### Margin from Annuity Products (dollars in millions):

| Annuity margin: Fixed index annuities | Three months ended June 30, 2020 | 2019 | Six months ended June 30, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| Insurance policy income | $2.6 | $2.8 | $5.9 | $5.9 |
| Net investment income | 82.9 | 76.0 | 165.0 | 151.3 |
| Insurance policy benefits | 104.1 | (.5) | 103.1 | — |
| Interest credited | (28.3) | (24.7) | (54.5) | (50.4) |
| Amortization and non-deferred commissions | (49.6) | (12.1) | (63.4) | (24.2) |
| Margin from fixed index annuities | $111.7 | $41.5 | $156.1 | $82.6 |
| Average net insurance liabilities | $7,056.3 | $6,388.9 | $6,988.9 | $6,291.3 |
| Margin/average net insurance liabilities | 6.33% | 2.60% | 4.47% | 2.63% |
| Fixed interest annuities |  |  |  |  |
| Insurance policy income | $.1 | $.4 | $.4 | $.9 |
| Net investment income | 26.8 | 31.2 | 54.9 | 64.0 |
| Insurance policy benefits | — | (.1) | (.1) | (.2) |
| Interest credited | (14.4) | (16.0) | (29.3) | (32.4) |
| Amortization and non-deferred commissions | (11.7) | (3.0) | (13.8) | (6.0) |
| Margin from fixed interest annuities | $.8 | $12.5 | $12.1 | $26.3 |
| Average net insurance liabilities | $2,088.2 | $2,337.9 | $2,117.2 | $2,377.6 |
| Margin/average net insurance liabilities | .15% | 2.14% | 1.14% | 2.21% |
| Other annuities |  |  |  |  |
| Insurance policy income | 1.8 | 1.0 | 3.8 | 4.0 |
| Net investment income | 6.9 | 7.6 | 14.1 | 15.3 |
| Insurance policy benefits | 3.6 | (4.5) | (.8) | (12.8) |
| Interest credited | (.9) | (.9) | (1.8) | (2.0) |
| Amortization and non-deferred commissions | (.1) | — | (.2) | — |
| Margin from other annuities | $11.3 | $3.2 | $15.1 | $4.5 |
| Average net insurance liabilities | $533.5 | $574.4 | $542.5 | $575.1 |
| Margin/average net insurance liabilities | 8.47% | 2.23% | 5.57% | 1.56% |
| Total annuity margin | $123.8 | $57.2 | $183.3 | $113.4 |
| Average net insurance liabilities | $9,678.0 | $9,301.2 | $9,648.6 | $9,244.0 |
| Margin/average net insurance liabilities | 5.12% | 2.46% | 3.80% | 2.45% |

***Margin from fixed index annuities*** was $111.7 million in the second quarter of 2020, compared to $41.5 million in 2019, and was $156.1 million in the first six months of 2020, compared to $82.6 million in 2019. The increase in margin is primarily due to: (i) the favorable impact of actuarial assumption changes previously discussed; and (ii) growth in the block. Average net insurance liabilities (total insurance liabilities less: (i) amounts related to reinsured business; (ii) deferred acquisition costs; (iii) present value of future profits; and (iv) the value of unexpired options credited to insurance liabilities) were $7,056.3 million and $6,388.9 million in the second quarters of 2020 and 2019, respectively, and were $6,988.9 million and $6,291.3 million in the first six months of 2020 and 2019, respectively, driven by deposits and reinvested returns in excess of withdrawals in periods subsequent to the second quarter of 2019. The increase in net insurance liabilities results in higher net investment income allocated, however, the earned yield was 4.70 percent in the second quarter of 2020 down from 4.76 percent in 2019, and was 4.72 percent in the first six months of 2020 down from 4.81 percent in 2019, reflecting lower market yields.

Net investment income and interest credited exclude the change in market values of the underlying options supporting the fixed index annuity products and corresponding offsetting amount credited to policyholder account balances. Such amounts were $44.9 million and $20.2 million in the second quarters of 2020 and 2019, respectively, and were $(75.0) million and $58.1 million in the first six months of 2020 and 2019, respectively.

***Margin from fixed interest annuities*** was $.8 million in the second quarter of 2020, compared to $12.5 million in 2019, and was $12.1 million in the first six months of 2020, compared to $26.3 million in 2019. The decrease in margin is primarily due to: (i) the unfavorable impact of actuarial assumption changes previously discussed; and (ii) a reduction in the size of the block. Average net insurance liabilities were $2,088.2 million in the second quarter of 2020 compared to $2,337.9 million in 2019 and were $2,117.2 million in the first six months of 2020 compared to $2,377.6 million in 2019, driven by withdrawals in excess of deposits and reinvested returns. The decrease in net insurance liabilities results in lower net investment income allocated. The earned yield decreased to 5.13 percent in the second quarter of 2020 from 5.34 percent in 2019 and to 5.19 percent in the first six months of 2020 from 5.38 percent in 2019, reflecting lower market yields.

***Margin from other annuities*** in the 2020 periods reflects favorable mortality compared to the same periods in the prior year. Annuitant mortality related to contracts with life contingencies resulted in a decrease in insurance liabilities and insurance policy benefits of $9.8 million in the second quarter of 2020.

### Margin from Health Products (dollars in millions):

| Health margin: Supplemental health | Three months ended June 30, 2020 | 2019 | Six months ended June 30, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| Insurance policy income | $169.8 | $164.4 | $339.6 | $327.6 |
| Net investment income | 34.9 | 34.7 | 69.8 | 69.7 |
| Insurance policy benefits | (138.1) | (128.9) | (271.0) | (252.0) |
| Amortization and non-deferred commissions | (26.2) | (27.8) | (55.8) | (55.4) |
| Margin from supplemental health | $40.4 | $42.4 | $82.6 | $89.9 |
| Margin/insurance policy income | 24% | 26% | 24% | 27% |
| Medicare supplement |  |  |  |  |
| Insurance policy income | $190.3 | $193.7 | $382.6 | $388.7 |
| Net investment income | 1.2 | 1.1 | 2.4 | 2.3 |
| Insurance policy benefits | (136.6) | (143.8) | (273.3) | (285.6) |
| Amortization and non-deferred commissions | (13.0) | (15.1) | (38.4) | (38.1) |
| Margin from Medicare supplement | $41.9 | $35.9 | $73.3 | $67.3 |
| Margin/insurance policy income | 22% | 19% | 19% | 17% |
| Total health margin | $82.3 | $78.3 | $155.9 | $157.2 |
| Margin/insurance policy income | 23% | 22% | 22% | 22% |

***Margin from supplemental health*** business was $40.4 million in the second quarter of 2020, down 4.7 percent from 2019, and was $82.6 million in the first six months of 2020, down 8.1 percent from 2019, driven primarily by a decrease in the margin as a percentage of insurance policy income to 24% in the second quarter of 2020 compared to 26% in the prior year period and 24% in first six months of 2020 compared to 27% in the prior year period. Insurance policy benefits in the 2019 periods reflected better claims experience than expected. Insurance policy income increased due to new sales in recent periods. Our margin on the supplemental health business in the second quarter of 2020 was unfavorably impacted by higher persistency resulting in a lower release of reserves, more than offsetting favorable claim experience. Such higher persistency primarily resulted from regulatory mandates and the Company's policy which delays the lapsation of policies due to the non-payment of premiums during the pandemic.

Our supplemental health products (including specified disease, accident and hospital indemnity products) generally provide fixed or limited benefits. For example, payments under cancer insurance policies are generally made directly to, or at the direction of, the policyholder following diagnosis of, or treatment for, a covered type of cancer. Approximately three-fourths of our supplemental health policies inforce (based on policy count) are sold with return of premium or cash value riders. The return of premium rider generally provides that after a policy has been inforce for a specified number of years or upon the

policyholder reaching a specified age, we will pay to the policyholder, or a beneficiary under the policy, the aggregate amount of all premiums paid under the policy, without interest, less the aggregate amount of all claims incurred under the policy. The cash value rider is similar to the return of premium rider, but also provides for payment of a graded portion of the return of premium benefit if the policy terminates before the return of premium benefit is earned. Accordingly, the net cash flows from these products generally result in the accumulation of amounts in the early years of a policy (reflected in our earnings as reserve increases which is a component of insurance policy benefits) which will be paid out as benefits in later policy years (reflected in our earnings as reserve decreases which offset the recording of benefit payments). As the policies age, insurance policy benefits will typically increase, but the increase in benefits will be partially offset by investment income earned on the accumulated assets.

***Margin from Medicare supplement*** business was $41.9 million and $35.9 million in the second quarters of 2020 and 2019, respectively, and was $73.3 million and $67.3 million in the first six months of 2020 and 2019, respectively. The increase in margin on the Medicare supplement business in the 2020 periods reflects favorable claim experience. Such favorable claim experience in the second quarter of 2020 may be attributable to policyholders deferring health care during the pandemic which may lead to higher claim costs in future periods. Insurance policy income was $190.3 million in the second quarter of 2020, down 1.8 percent from 2019, and was $382.6 million in the first six months of 2020, down 1.6 percent from 2019, reflecting lower sales in recent periods partially offset by premium rate increases.

Medicare supplement business consists of both individual and group policies. Government regulations generally require we attain and maintain a ratio of total benefits incurred to total premiums earned (excluding changes in policy benefits reserves which is a component of Insurance policy benefits) of not less than 65 percent on individual products and not less than 75 percent on group products. The ratio is determined after three years from the original issuance of the policy and over the lifetime of the policy and measured in accordance with statutory accounting principles. Since the insurance product liabilities we establish for Medicare supplement business are subject to significant estimates, the ultimate claim liability we incur for a particular period is likely to be different than our initial estimate. Changes to our estimates are reflected in Insurance policy benefits in the period the change is determined.

### Margin from Life Products (dollars in millions):

| Life margin: Interest-sensitive life | Three months ended June 30, 2020 | 2019 | Six months ended June 30, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| Insurance policy income | $38.7 | $37.3 | $78.3 | $73.5 |
| Net investment income | 11.7 | 11.7 | 23.4 | 23.3 |
| Insurance policy benefits | (23.2) | (14.9) | (38.9) | (30.8) |
| Interest credited | (10.7) | (10.4) | (20.9) | (20.4) |
| Amortization and non-deferred commissions | (4.8) | (7.1) | (12.2) | (14.1) |
| Margin from interest-sensitive life | $11.7 | $16.6 | $29.7 | $31.5 |
| Average net insurance liabilities | $913.5 | $860.7 | $906.8 | $856.4 |
| Interest margin | $1.0 | $1.3 | $2.5 | $2.9 |
| Interest margin/average net insurance liabilities | .44% | .60% | .55% | .68% |
| Underwriting margin | $10.7 | $15.3 | $27.2 | $28.6 |
| Underwriting margin/insurance policy income | 28% | 41% | 35% | 39% |
| Traditional life |  |  |  |  |
| Insurance policy income | $155.6 | $151.7 | $310.1 | $302.7 |
| Net investment income | 23.0 | 23.1 | 45.6 | 46.0 |
| Insurance policy benefits | (124.6) | (111.3) | (240.8) | (226.2) |
| Interest credited | (.2) | (.2) | (.3) | (.4) |
| Amortization and non-deferred commissions | (13.2) | (13.2) | (27.7) | (27.1) |
| Advertising expense | (16.2) | (15.0) | (36.2) | (31.7) |
| Margin from traditional life | $24.4 | $35.1 | $50.7 | $63.3 |
| Margin/insurance policy income | 16% | 23% | 16% | 21% |
| Margin excluding advertising expense/insurance policy income | 26% | 33% | 28% | 31% |
| Total life margin | $36.1 | $51.7 | $80.4 | $94.8 |

***Margin from interest-sensitive life*** business was $11.7 million in the second quarter of 2020, down 30 percent from 2019, and was $29.7 million in the first six months of 2020, down 5.7 percent from 2019. The decrease in margin is primarily due to: (i) the unfavorable impact of actuarial assumptions previously discussed; partially offset by (ii) growth in the block due to sales in recent periods. In addition, we estimate that the impact from death claims related to COVID-19 on the margin of this block of business was approximately $1 million in the second quarter of 2020.

The interest margin was $1.0 million and $1.3 million in the second quarters of 2020 and 2019, respectively, and was $2.5 million and $2.9 million in the first six months of 2020 and 2019, respectively. Net investment income in the 2020 periods is comparable to the 2019 periods. The increase in average net insurance liabilities results in higher net investment income allocated, however, the decrease in earned yield has resulted in net investment income being flat compared to the prior year. The earned yield was 5.12 percent and 5.44 percent in the second quarters of 2020 and 2019, respectively, and 5.16 percent and 5.44 percent in the first six months of 2020 and 2019, respectively. Interest credited to policyholders may be changed annually but are subject to minimum guaranteed rates and, as a result, the reduction in our earned rate was not fully reflected in the rate credited to policyholders.

Net investment income and interest credited excludes the change in market values of the underlying options supporting the fixed index life products and corresponding offsetting amount credited to policyholder account balances. Such amounts were $5.8 million and $2.9 million in the second quarters of 2020 and 2019, respectively, and were $(10.8) million and $8.6 million in the first six months of 2020 and 2019, respectively.

***Margin from Traditional life*** business was $24.4 million in the second quarter of 2020, down 30 percent from 2019, and was $50.7 million in the first six months of 2020, down 20 percent from 2019. Insurance policy income was $155.6 million in the second quarter of 2020, up 2.6 percent from the 2019 period, and was $310.1 million in the first six months of 2020, up 2.4 percent from the 2019 period, reflecting new sales and persistency in the block. Insurance policy benefits were $124.6 million in the second quarter of 2020, up 12 percent from the same period in 2019, and were $240.8 million in the first six months of 2020, up 6.5 percent from the 2019 period. We estimate that the impact from death claims related to COVID-19 increased insurance policy benefits by approximately $13 million in the second quarter of 2020.

Allocated net investment income in the 2020 periods was comparable to the 2019 periods, as the growth in the block was offset by lower average investment yields in the 2020 periods.

Advertising expense was $16.2 million in the second quarter of 2020, up $1.2 million from the comparable period in 2019, and was $36.2 million in the first six months of 2020, up $4.5 million from the comparable period in 2019. The demand and cost of television advertising can fluctuate from period to period. We are disciplined with our marketing expenditures and will increase or decrease our marketing spend depending on prices.

### Margin from Long-term Care Products (dollars in millions):

| Long-term care margin: | Three months ended June 30, 2020 | 2019 | Six months ended June 30, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| Insurance policy income | $66.4 | $67.0 | $133.3 | $134.3 |
| Net investment income | 34.0 | 34.0 | 68.3 | 67.3 |
| Insurance policy benefits | (84.3) | (85.7) | (168.5) | (171.2) |
| Amortization and non-deferred commissions | (2.9) | (3.4) | (6.6) | (7.0) |
| Margin from long-term care | $13.2 | $11.9 | $26.5 | $23.4 |
| Margin/insurance policy income | 20% | 18% | 20% | 17% |

***Margin from Long-term care products*** was $13.2 million in the second quarter of 2020, up 11 percent from 2019, and was $26.5 million in the first six months of 2020, up 13 percent from 2019. The margin as a percentage of insurance policy income increased to 20% in the second quarter of 2020 compared to 18% in the second quarter of 2019 and to 20% in the first six months of 2020 compared to 17% in the first six months of 2019. The margin in the 2020 periods benefited from reserve releases due to deaths that occurred as well as lower claims incurred attributable to policyholders deferring health care during the pandemic.

### Collected Premiums From Annuity and Interest-Sensitive Life Products (dollars in millions):

| Collected premiums from annuity and interest-sensitive life products: | Three months ended June 30, 2020 | 2019 | Six months ended June 30, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| Annuities | $242.7 | $341.2 | $534.9 | $656.9 |
| Interest-sensitive life | 51.3 | 51.9 | 104.4 | 99.4 |
| Total collected premiums from annuity and interest-sensitive life products | $294.0 | $393.1 | $639.3 | $756.3 |

Collected premiums from annuity and interest-sensitive products decreased 25 percent in the second quarter of 2020, compared to the second quarter of 2019 and 15 percent in the first six months of 2020, compared to the first six months of 2019, primarily due to lower premium collections from fixed index products. We have proactively managed the participation rates on our fixed index products in order to balance sales growth and profitability in the current low interest rate environment.

### Investment Income Not Allocated to Product Lines (dollars in millions):

|  | Three months ended June 30, 2020 | 2019 | Six months ended June 30, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| Net investment income | $318.8 | $334.5 | $488.4 | $690.3 |
| Allocated to product lines: |  |  |  |  |
| Annuity | (116.6) | (114.8) | (234.0) | (230.6) |
| Health | (36.1) | (35.8) | (72.2) | (72.0) |
| Life | (34.7) | (34.8) | (69.0) | (69.3) |
| Long-term care | (34.0) | (34.0) | (68.3) | (67.3) |
| Equity returns credited to policyholder account balances | (50.7) | (23.1) | 85.8 | (66.7) |
| Amounts allocated to product lines and credited to policyholder account balances | (272.1) | (242.5) | (357.7) | (505.9) |
| Amount related to variable interest entities and other non-operating items | (9.6) | (16.0) | (21.2) | (35.2) |
| Interest expense on debt | (13.6) | (12.6) | (27.2) | (24.7) |
| Interest expense on investment borrowings | (5.8) | (12.3) | (14.9) | (24.7) |
| Less amounts credited to deferred compensation plans (offsetting investment income) | (9.5) | (2.8) | (1.8) | (8.2) |
| Total adjustments | (38.5) | (43.7) | (65.1) | (92.8) |
| Investment income not allocated to product lines | $8.2 | $48.3 | $65.6 | $91.6 |

The above table reconciles net investment income to investment income not allocated to product lines. Such amount will fluctuate from period to period based on the level of prepayment income (including call premiums); the performance of our alternative investments (which are typically reported a quarter in arrears); and the earnings related to the investments underlying our COLI. The decrease in investment income not allocated to product lines in the 2020 periods can be attributed to lower variable investment income including income (loss) on alternative investments and prepayment and call income.

### Net Non-Operating Income (Loss) (dollars in millions):

The following summarizes our net non-operating income (loss) for the three and six months ending June 30, 2020 and 2019 (dollars in millions):

|  | Three months ended June 30, 2020 | 2019 | Six months ended June 30, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| Net realized investment gains (losses) losses from sales, impairments and change in allowance for credit losses (net of related amortization) | $12.3 | $(1.7) | $(51.4) | $(2.4) |
| Net change in market value of investments recognized in earnings | 31.2 | 6.8 | (17.2) | 23.4 |
| Fair value changes related to agent deferred compensation plan | (13.2) | (11.6) | (13.2) | (16.9) |
| Fair value changes in embedded derivative liabilities (net of related amortization) | (27.1) | (35.9) | (93.8) | (65.5) |
| Loss on extinguishment of debt | — | (7.3) | — | (7.3) |
| Other | — | .7 | 2.3 | 1.9 |
| Net non-operating income (loss) before taxes | $3.2 | $(49.0) | $(173.3) | $(66.8) |

Net realized investment gains (losses), net of related amortization, in the three and six months ended June 30, 2020, were $12.3 million and $(51.4) million, respectively, including an (increase) decrease in the allowance for credit losses and other-than-temporary impairment losses of $15.9 million and $(39.5) million, respectively, which were recorded in earnings. The increase in the allowance for credit losses in the first six months of 2020 reflects the market volatility and other impacts of the COVID-19 pandemic. We anticipate continued volatility and the potential for additional increases to the allowance for credit losses in future periods. Net realized investment losses in the first six months of 2019 were $2.4 million (net of related amortization) including other-than-temporary impairment losses of $2.2 million which were recorded in earnings.

During the first six months of 2020 and 2019, we recognized an increase (decrease) in earnings of $(17.2) million and $23.4 million, respectively, due to the net change in market value of investments recognized in earnings.

During the first six months of 2020 and 2019, we recognized a decrease in earnings of $13.2 million and $16.9 million, respectively, for the mark-to-market change in the agent deferred compensation plan liability which was impacted by changes in the underlying actuarial assumptions used to value the liability. We recognize the mark-to-market change in the estimated value of this liability through earnings as assumptions change.

During the first six months of 2020 and 2019, we recognized a decrease in earnings of $93.8 million and $65.5 million, respectively, resulting from changes in the estimated fair value of embedded derivative liabilities related to our fixed index annuities, net of related amortization. Such amounts include the impacts of changes in market interest rates used to determine the derivative's estimated fair value. At June 30, 2020, the weighted average discount rate used to value this liability was .85 percent compared to 1.88 percent at December 31, 2019. The discount rate is based on risk-free rates (U.S. Treasury rates for similar durations) adjusted for non-performance risk and risk margins for non-capital market inputs. The significant decrease in U.S. Treasury rates in the first six months of 2020 was the primary factor in the change in estimated fair value of the embedded derivative liabilities.

Loss on extinguishment of debt in the 2019 periods of $7.3 million consisted of: (i) a premium of $6.1 million due to the redemption of the 4.500% Senior Notes due May 2020 (the "2020 Notes"); and (ii) $1.2 million related to the write-off of unamortized issuance costs due to the redemption of the 2020 Notes.

### LIQUIDITY AND CAPITAL RESOURCES

### Potential Impacts of COVID-19 Pandemic

We expect the potential impact of the pandemic on our results will be largely driven by three things which are already impacting our business, but the duration and severity of which are currently unknown:

- the impact of social distancing on our sales volumes;
- changes in mortality, morbidity, and persistency (or lapse rates) impacting insurance product margin; and
- the resulting economic recession driving: (i) lower net investment income through lower interest rates; (ii) the impact of credit deterioration on invested assets and capital; and (iii) potential impacts to reserves and deferred acquisition costs resulting from lower interest rates.

Given the ongoing uncertainty related to how the COVID-19 pandemic will impact our results and the continued economic impact it will have, we continue to model a range of potential outcomes across these three dimensions. The purpose of our modeling is not to predict certain outcomes, but to develop a range of potential outcomes and manage capital and liquidity in the context of outcomes within the range. We most recently updated our models for two scenarios in July 2020. These scenarios incorporate many assumptions and actual conditions in future periods may differ materially from the assumptions used in modeling the two scenarios. In the first scenario, we assumed 150,000 deaths from the virus in the United States, with the economy recovering in the third quarter of 2020 and with muted economic growth in the fourth quarter of 2020. In the second scenario, we assumed 400,000 deaths from the virus in the United States, with more modest economic growth in the third quarter of 2020 and with a second wave of economic recession beginning in the fourth quarter of 2020.

With respect to the impact of the COVID-19 pandemic on sales volumes, we expect our consolidated results in the second half of 2020 to continue to be challenged, but with positive momentum during the period. In the second quarter of 2020, our Consumer Division life, health and long-term care sales (new annualized premiums) were down 10 percent and collected premiums from our annuity products were down 29 percent from the same period in the prior year. To the extent the economy continues to reopen and as our customers and agents become more accustomed to virtual transactions, sales in the Consumer Division are expected to improve.

The path to recovery within our Worksite Division is proving to be more difficult. In the second quarter of 2020, our Worksite Division life and health sales (new annualized premiums) were down 69 percent compared to the same period in the prior year. We currently expect sales in the Worksite Division to remain challenged through the third quarter of 2020 and begin to improve in the fourth quarter in conjunction with open enrollment periods.

With respect to changes in mortality and morbidity, based on the modeling of the two scenarios described above we estimate that COVID-19 related claims could have a net adverse impact on our full year 2020 total insurance product margin in the range of approximately $20 million to $52 million across the two scenarios. In the second quarter of 2020, our margin on life insurance products reflected an estimated $14 million adverse mortality impact related to COVID-19. While higher mortality claims unfavorably impact our life product margins, we anticipate that our health and long-term care margins will generally benefit through a related release of reserves in the second half of 2020. Physical distancing practices related to COVID-19 had a significant favorable impact on paid claims in the second quarter of 2020 in our health and long-term care businesses as consumers deferred medical and/or long-term care treatments. We expect some portion of this trend to reverse in some subsequent quarter, as and when physical distancing practices are relaxed.

We believe there is a possibility that high unemployment could translate to an increase in lapse rates in future periods. If higher lapse rates do occur, we expect that current period earnings would generally be favorably impacted but earnings in future periods would be unfavorably impacted, as the base of our inforce business would be lower.

Regarding our investment portfolio, we have evaluated a range of potential impacts from the pandemic, including impacts on credit migration, default levels, net investment income and capital. We used a range of assumptions which are market-consistent, or in-line with downside assumptions from rating agencies and consistent with past financial crises. Our evaluation focused in particular on COVID-19 impacted sectors such as real estate, airlines, retail, hospitality, and energy, among others.

With respect to the collective impact of the COVID-19 pandemic on earnings, we expect our operating earnings in the second half of 2020 to be lower than the prior year period. This is driven by the expectation of lower investment yields and due to the impact of COVID-19 claims on insurance product margins.

We believe our earnings over the long-term will be impacted by lower interest rates consistent with the assumptions reflected in our actuarial unlocking exercise in the second quarter of 2020. Refer to "Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations - Changes in Actuarial Assumptions in the Second Quarter of 2020" for further information related to changes in certain actuarial assumptions and their impact on our operating results in the second quarter of 2020.

With respect to capital, based on the modeling described above, even with the more adverse impacts of the second scenario, we believe we would be able to:

- maintain our target RBC levels, debt to capital ratios and minimum holding company liquidity;
- maintain our quarterly dividend to shareholders; and
- have continued capacity for modest share repurchases.

The two modeling scenarios described above, and the resulting range of estimated outcomes, are hypothetical and have been provided to give a general sense of how certain aspects of our business could be affected by COVID-19, depending on the duration and severity of the pandemic and related governmental and social responses and the economic consequences of the pandemic. There are many modeling scenarios which could result in materially different projected outcomes from the two described above and, accordingly the modeling scenarios described above do not constitute an exclusive set of possible outcomes resulting from COVID-19 which could affect our business, results of operations, financial condition and liquidity. Similarly, given the unprecedented nature of the COVID-19 pandemic, the assumptions used in these modeling scenarios, and the related range of outcomes, are based on assumed facts which are inherently unpredictable and, accordingly, if the pandemic progresses and updated assumptions were to be applied to the modeling scenarios the outcome generated by the application of updated assumptions to these modeling scenarios may be materially different from those described above. For example, the actual number of U.S. deaths and the related economic impacts from COVID-19 may differ materially from the assumptions used to generate the outcomes from the two scenarios. In this regard, we note that while the number of presumed COVID-19 related deaths at the time we modeled the financial impacts to us of COVID-19 was less than our low end assumptions of 150,000, as of the date of this filing the number of reported presumed deaths from the virus in the United States exceeds 150,000. In addition, policies and actions taken by the United States government have mitigated the impacts of COVID-19 on the financial markets, investment performance and valuations. There can be no assurance that these policies will continue. If the economic impact of COVID-19 is ultimately worse than contemplated by our modeled scenarios, the impact to our business, results of operations, financial condition and liquidity could be significantly different than described above.

Our capital structure as of June 30, 2020 and December 31, 2019 was as follows (dollars in millions):

| Total capital: | June 30, 2020 | December 31, 2019 |
| --- | ---: | ---: |
| Corporate notes payable | $989.7 | $989.1 |
| Shareholders’ equity: |  |  |
| Common stock | 1.4 | 1.5 |
| Additional paid-in capital | 2,664.3 | 2,767.3 |
| Accumulated other comprehensive income | 1,520.2 | 1,372.5 |
| Retained earnings | 545.3 | 535.7 |
| Total shareholders’ equity | 4,731.2 | 4,677.0 |
| Total capital | $5,720.9 | $5,666.1 |

The following table summarizes certain financial ratios as of and for the six months ended June 30, 2020 and as of and for the year ended December 31, 2019:

|  | June 30, 2020 | December 31, 2019 |
| --- | ---: | ---: |
| Book value per common share | $33.38 | $31.58 |
| Book value per common share, excluding accumulated other comprehensive income (a) | 22.66 | 22.32 |
| Debt to total capital ratios: |  |  |
| Corporate debt to total capital | 17.3% | 17.5% |
| Corporate debt to total capital, excluding accumulated other comprehensive income (a) | 23.6% | 23.0% |

(a) This non-GAAP measure differs from the corresponding GAAP measure presented immediately above, because accumulated other comprehensive income has been excluded from the value of capital used to determine this measure. Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in accumulated other comprehensive income. Such volatility is often caused by changes in the estimated fair value of our investment portfolio resulting from changes in general market interest rates rather than the business decisions made by management. However, this measure does not replace the corresponding GAAP measure.

### Liquidity for Insurance Operations

Our insurance companies generally receive adequate cash flows from premium collections and investment income to meet their obligations. Life insurance, long-term care insurance and annuity liabilities are generally long-term in nature. Life and annuity policyholders may, however, withdraw funds or surrender their policies, subject to any applicable penalty provisions; there are generally no withdrawal or surrender benefits for long-term care insurance. We actively manage the relationship between the duration of our invested assets and the estimated duration of benefit payments arising from contract liabilities.

Three of the Company's insurance subsidiaries (Bankers Life, Washington National and Colonial Penn) are members of the FHLB. As members of the FHLB, our insurance subsidiaries have the ability to borrow on a collateralized basis from the FHLB. We are required to hold certain minimum amounts of FHLB common stock as a condition of membership in the FHLB, and additional amounts based on the amount of the borrowings. At June 30, 2020, the carrying value of the FHLB common stock was $71.0 million. As of June 30, 2020, collateralized borrowings from the FHLB totaled $1.6 billion and the proceeds were used to purchase fixed maturity securities. The borrowings are classified as investment borrowings in the accompanying consolidated balance sheet. The borrowings are collateralized by investments with an estimated fair value of $2.1 billion at June 30, 2020, which are maintained in custodial accounts for the benefit of the FHLB.

State laws generally give state insurance regulatory agencies broad authority to protect policyholders in their jurisdictions. Regulators have used this authority in the past to restrict the ability of our insurance subsidiaries to pay any dividends or other amounts without prior approval. We cannot be assured that the regulators will not seek to assert greater supervision and control over our insurance subsidiaries' businesses and financial affairs.

Our estimated consolidated statutory RBC ratio was 405 percent at June 30, 2020, compared to 408 percent at December 31, 2019. The decrease is primarily due to a 29 percentage point decrease in investment valuation-related items which were substantially offset by statutory operating earnings and the impacts of a change in principle related to certain reserve calculations, net of dividends paid to the holding company. In the first six months of 2020, our estimated consolidated statutory operating earnings were $228 million and insurance company dividends of $130.3 million were paid to the holding company. Statutory operating income and capital and surplus were favorably impacted by $99 million and $53 million, respectively, related to certain provisions in the CARES Act. The favorable impact resulted from provisions that permitted the carryback of net operating losses that were created after 2017 and the temporary repeal of the 80% limitation on the utilization of NOLs created after 2017.

Our insurance subsidiaries transfer exposure to certain risk to others through reinsurance arrangements. When we obtain reinsurance, we are still liable for those transferred risks in the event the reinsurer defaults on its obligations. The failure, insolvency, inability or unwillingness of one or more of the Company's reinsurers to perform in accordance with the terms of its reinsurance agreement could negatively impact our earnings or financial position and our consolidated statutory RBC ratio.

### Financial Strength Ratings of our Insurance Subsidiaries

Financial strength ratings provided by Fitch Ratings ("Fitch"), A.M. Best Company ("A.M. Best"), S&P and Moody's Investor Services, Inc. ("Moody's") are the rating agency's opinions of the ability of our insurance subsidiaries to pay policyholder claims and obligations when due.

On April 21, 2020, Fitch affirmed its "A-" financial strength ratings of our primary insurance subsidiaries. The outlook for these ratings remain stable. An insurer rated "A", in Fitch's opinion, indicates a low expectation of ceased or interrupted payments and indicates strong capacity to meet policyholder and contract obligations. This capacity may, nonetheless, be more vulnerable to changes in circumstances or in economic conditions than is the case for higher ratings. Fitch ratings for the industry range from "AAA Exceptionally Strong" to "C Distressed" and some companies are not rated. Pluses and minuses show the relative standing within a category. Fitch has nineteen possible ratings. There are six ratings above the "A-" rating of our primary insurance subsidiaries and twelve ratings that are below that rating.

On January 29, 2020, A.M. Best affirmed its "A-" financial strength ratings of our primary insurance subsidiaries. The outlook for these ratings remain stable. The "A-" rating is assigned to companies that have an excellent ability, in A.M. Best's opinion, to meet their ongoing obligations to policyholders. A.M. Best ratings for the industry currently range from "A++ (Superior)" to "F (In Liquidation)" and some companies are not rated. An "A++" rating indicates a superior ability to meet ongoing obligations to policyholders. A.M. Best has sixteen possible ratings. There are three ratings above the "A-" rating of our primary insurance subsidiaries and twelve ratings that are below that rating.

On June 21, 2019, S&P upgraded the financial strength ratings of our primary insurance subsidiaries to "A-" from

"BBB+" and the outlook for these ratings is stable. S&P financial strength ratings range from "AAA" to "R" and some companies are not rated. An insurer rated "A", in S&P's opinion, has strong financial security characteristics, but is somewhat more likely to be affected by adverse business conditions than are insurers with higher ratings. Pluses and minuses show the relative standing within a category. S&P has twenty-one possible ratings. There are six ratings above the "A-" rating of our primary insurance subsidiaries and fourteen ratings that are below that rating.

On October 4, 2018, Moody's upgraded the financial strength ratings of our primary insurance subsidiaries to "A3" from "Baa1" and the outlook for these ratings is stable. Moody's actions resulted from the Company's announcement that Bankers Life had closed on its agreement to cede certain long-term care policies. Moody’s financial strength ratings range from "Aaa" to "C". These ratings may be supplemented with numbers "1", "2", or "3" to show relative standing within a category. In Moody's view, an insurer rated "A" offers good financial security, however, certain elements may be present which suggests a susceptibility to impairment sometime in the future. Moody's has twenty-one possible ratings. There are six ratings above the "A3" rating of our primary insurance subsidiaries and fourteen ratings that are below that rating.

Rating agencies have increased the frequency and scope of their credit reviews and requested additional information from the companies that they rate, including us. They may also adjust upward the capital and other requirements employed in the rating agency models for maintenance of certain ratings levels. We cannot predict what actions rating agencies may take, or what actions we may take in response. Accordingly, downgrades and outlook revisions related to us or the life insurance industry may occur in the future at any time and without notice by any rating agency. These could increase policy surrenders and withdrawals, adversely affect relationships with our distribution channels, reduce new sales, reduce our ability to borrow and increase our future borrowing costs.

### Liquidity of the Holding Companies

*Availability and Sources and Uses of Holding Company Liquidity; Limitations on Ability of Insurance Subsidiaries to Make Dividend and Surplus Debenture Interest Payments to the Holding Companies; Limitations on Holding Company Activities*

At June 30, 2020, CNO, CDOC, Inc. ("CDOC", our wholly owned subsidiary and the immediate parent of Washington National and Conseco Life Insurance Company of Texas ("CLTX")) and our other non-insurance subsidiaries held unrestricted cash and cash equivalents of $208.0 million. CNO and CDOC are holding companies with no business operations of their own; they depend on their operating subsidiaries for cash to make principal and interest payments on debt, and to pay administrative expenses and income taxes. CNO and CDOC receive cash from insurance subsidiaries, consisting of dividends and distributions, interest payments on surplus debentures and tax-sharing payments, as well as cash from non-insurance subsidiaries consisting of dividends, distributions, loans and advances. The principal non-insurance subsidiaries that provide cash to CNO and CDOC are 40\|86 Advisors, Inc., which receives fees from the insurance subsidiaries for investment services, and CNO Services, LLC which receives fees from the insurance subsidiaries for providing administrative services. The agreements between our insurance subsidiaries and CNO Services, LLC and 40\|86 Advisors, Inc., respectively, were previously approved by the domestic insurance regulator for each insurance company, and any payments thereunder do not require further regulatory approval.

The following summarizes the current ownership structure of CNO’s primary subsidiaries:

The ability of our insurance subsidiaries to pay dividends is subject to state insurance department regulations and is based on the financial statements of our insurance subsidiaries prepared in accordance with statutory accounting practices prescribed or permitted by regulatory authorities, which differ from GAAP. These regulations generally permit dividends to be paid from statutory earned surplus of the insurance company without regulatory approval for any 12-month period in amounts equal to the greater of (or in some states, the lesser of): (i) statutory net gain from operations or net income for the prior year; or (ii) 10 percent of statutory capital and surplus as of the end of the preceding year. However, as each of the immediate insurance subsidiaries of CDOC has significant negative earned surplus, any dividend payments from the insurance subsidiaries require the prior approval of the director or commissioner of the applicable state insurance department. In the first six months of 2020, our insurance subsidiaries paid dividends to CDOC totaling $130.3 million. We expect to receive regulatory approval for future dividends from our subsidiaries, but there can be no assurance that such payments will be approved or that the financial condition of our insurance subsidiaries will not change, making future approvals less likely.

CDOC holds surplus debentures from CLTX with an aggregate principal amount of $749.6 million. Interest payments on those surplus debentures do not require additional approval provided the RBC ratio of CLTX exceeds 100 percent (but do require prior written notice to the Texas state insurance department). The estimated RBC ratio of CLTX was 352 percent at June 30, 2020. CDOC also holds a surplus debenture from Colonial Penn with a principal balance of $160.0 million. Interest payments on that surplus debenture require prior approval by the Pennsylvania state insurance department. Dividends and other payments from our non-insurance subsidiaries, including 40\|86 Advisors, Inc. and CNO Services, LLC, to CNO or CDOC do not require approval by any regulatory authority or other third party. However, insurance regulators may prohibit payments by our insurance subsidiaries to parent companies if they determine that such payments could be adverse to our policyholders or contractholders.

The insurance subsidiaries of CDOC receive funds to pay dividends primarily from: (i) the earnings of their direct businesses; (ii) tax sharing payments received from subsidiaries (if applicable); and (iii) with respect to CLTX, dividends received from subsidiaries. At June 30, 2020, the subsidiaries of CLTX had earned surplus (deficit) as summarized below (dollars in millions):

| Subsidiaries of CLTX | Earned surplus (deficit) | Additional information |
| --- | ---: | --- |
| Bankers Life | $256.0 | (a) |
| Colonial Penn | (354.8) | (b) |

(a) Bankers Life paid cash dividends of $125.0 million to CLTX in the first six months of 2020. Bankers Life may pay dividends without regulatory approval or prior notice for any 12-month period if such dividends are less than the greater of: (i) statutory net income for the prior year; or (ii) 10 percent of statutory capital and surplus as of the end of the preceding year. Dividends in excess of these levels require 30 days prior notice.

(b) The deficit is primarily due to transactions which occurred several years ago, including a tax planning transaction and the fee paid to recapture a block of business previously ceded to an unaffiliated insurer.

A significant deterioration in the financial condition, earnings or cash flow of the material subsidiaries of CNO or CDOC for any reason could hinder such subsidiaries' ability to pay cash dividends or other disbursements to CNO and/or CDOC, which, in turn, could limit CNO's ability to meet debt service requirements and satisfy other financial obligations. In addition, we may choose to retain capital in our insurance subsidiaries or to contribute additional capital to our insurance subsidiaries to maintain or strengthen their surplus or fund a long-term care reinsurance transaction, and these decisions could limit the amount available at our top tier insurance subsidiaries to pay dividends to the holding companies.

At June 30, 2020, there are no amounts outstanding under our Revolving Credit Agreement and there are no scheduled repayments of our direct corporate obligations until May 2025.

Free cash flow is a measure of holding company liquidity and is calculated as: (i) dividends, management fees and surplus debenture interest payments received from our subsidiaries; plus (ii) earnings on corporate investments; less (iii) interest expense, corporate expenses and net tax payments. In the first six months of 2020, we generated approximately $173 million of such free cash flow. The Company is committed to deploying 100 percent of its free cash flow into investments to accelerate profitable growth, common stock dividends and share repurchases. In late June 2020, we resumed share repurchase activity after suspending such share repurchases in mid-March 2020 in light of the uncertainty related to the COVID-19 pandemic. We expect to have capacity to continue modest share repurchases in the second half of 2020. The amount and timing of future share repurchases (if any) will be based on business and market conditions and other factors including, but not limited to, available free cash flows, the current price of our common stock and investment opportunities. In the first six months of 2020, we repurchased 7.1 million shares of common stock for $113.0 million under our securities repurchase program. The Company had remaining repurchase authority of $419.3 million as of June 30, 2020.

In the first six months of 2020, dividends declared on common stock totaled $33.4 million ($0.23 per common share). In May 2020, the Company increased its quarterly common stock dividend to $0.12 per share from $0.11 per share.

On April 21, 2020, Fitch affirmed its "BBB-" rating on our senior unsecured debt. The outlook for these ratings remain stable. In Fitch's view, an obligation rated "BBB" indicates that expectations of default risk are currently low. The capacity for payment of financial commitments is considered adequate but adverse business or economic conditions are more likely to impair this capacity. Pluses and minuses show the relative standing within a category. Fitch has a total of 21 possible ratings ranging from "AAA" to "D". There are nine ratings above CNO's "BBB-" rating and eleven ratings that are below its rating.

On January 29, 2020, A.M. Best affirmed its "bbb-" issuer credit and senior unsecured debt ratings. The outlook for these ratings remain stable. In A.M. Best's view, a company rated "bbb-" has an adequate ability to meet the terms of its obligations; however, the issuer is more susceptible to changes in economic or other conditions. Pluses and minuses show the relative standing within a category. A.M. Best has a total of 22 possible ratings ranging from "aaa (Exceptional)" to "d (In default)". There are nine ratings above CNO's "bbb-" rating and twelve ratings that are below its rating.

On June 21, 2019, S&P upgraded our senior unsecured debt rating to "BBB-" from "BB+" and the outlook for these ratings is stable. In S&P's view, an obligation rated "BBB" exhibits adequate protection parameters. However, adverse economic conditions or changing circumstances are more likely to lead to a weakened capacity of the obligor to meet its financial commitment on the obligation. Pluses and minuses show the relative standing within a category. S&P has a total of 22 possible ratings ranging from "AAA (Extremely Strong)" to "D (Payment Default)". There are nine ratings above CNO's "BBB-" rating and twelve ratings that are below its rating.

On October 4, 2018, Moody's upgraded our senior unsecured debt rating to "Baa3" from "Ba1" and the outlook for these ratings is stable. Moody's actions resulted from the Company's announcement that Bankers Life had closed on its agreement to cede certain long-term care policies. In Moody's view, obligations rated "Baa" are subject to moderate credit risk and may possess certain speculative characteristics. A rating is supplemented with numerical modifiers "1", "2" or "3" to show the relative standing within a category. Moody's has a total of 21 possible ratings ranging from "Aaa" to "C". There are nine ratings above CNO's "Baa3" rating and eleven ratings that are below its rating.

We believe that the existing cash available to the holding company, the cash flows to be generated from operations and other transactions will be sufficient to allow us to meet our debt service obligations, pay corporate expenses and satisfy other financial obligations. However, our cash flow is affected by a variety of factors, many of which are outside of our control, including insurance regulatory issues, competition, financial markets and other general business conditions. We cannot provide assurance that we will possess sufficient income and liquidity to meet all of our debt service requirements and other holding company obligations.

### INVESTMENTS

At June 30, 2020, the amortized cost, gross unrealized gains, gross unrealized losses, allowance for credit losses and estimated fair value of fixed maturities, available for sale, were as follows (dollars in millions):

| Investment grade (a): | Amortized cost | Gross unrealized gains | Gross unrealized losses | Allowance for credit losses | Estimated fair value |
| --- | ---: | ---: | ---: | ---: | ---: |
| Corporate securities | $10,908.4 | $2,010.4 | $(33.1) | $(2.6) | $12,883.1 |
| United States Treasury securities and obligations of United States government corporations and agencies | 151.3 | 79.0 | — | — | 230.3 |
| States and political subdivisions | 2,161.5 | 316.3 | (3.3) | (.5) | 2,474.0 |
| Foreign governments | 85.6 | 15.9 | — | — | 101.5 |
| Asset-backed securities | 1,084.6 | 27.0 | (18.2) | (.3) | 1,093.1 |
| Agency residential mortgage-backed securities | 67.8 | 7.6 | — | — | 75.4 |
| Non-agency residential mortgage-backed securities | 907.9 | 38.4 | (2.7) | — | 943.6 |
| Commercial mortgage-backed securities | 1,810.8 | 59.0 | (43.5) | — | 1,826.3 |
| Collateralized loan obligations | 457.6 | — | (15.1) | — | 442.5 |
| Total investment grade fixed maturities, available for sale | 17,635.5 | 2,553.6 | (115.9) | (3.4) | 20,069.8 |
| Below-investment grade (a) (b): |  |  |  |  |  |
| Corporate securities | 742.8 | 24.0 | (14.9) | (7.4) | 744.5 |
| States and political subdivisions | 12.9 | — | (3.5) | — | 9.4 |
| Asset-backed securities | 87.8 | .2 | (5.7) | — | 82.3 |
| Non-agency residential mortgage-backed securities | 1,092.4 | 110.1 | (7.9) | — | 1,194.6 |
| Commercial mortgage-backed securities | 70.2 | .5 | (3.4) | — | 67.3 |
| Total below-investment grade fixed maturities, available for sale | 2,006.1 | 134.8 | (35.4) | (7.4) | 2,098.1 |
| Total fixed maturities, available for sale | $19,641.6 | $2,688.4 | $(151.3) | $(10.8) | $22,167.9 |

(a) Investment ratings are assigned the second lowest rating by Nationally Recognized Statistical Rating Organizations ("NRSROs") (Moody's, S&P or Fitch), or if not rated by such firms, the rating assigned by the National Association of Insurance Commissioners (the "NAIC"). NAIC designations of "1" or "2" include fixed maturities generally rated investment grade (rated "Baa3" or higher by Moody's or rated "BBB-" or higher by S&P and Fitch). NAIC designations of "3" through "6" are referred to as below-investment grade (which generally are rated "Ba1" or lower by Moody's or rated "BB+" or lower by S&P and Fitch). References to investment grade or below-investment grade throughout our consolidated financial statements are determined as described above.

(b) Certain structured securities rated below-investment grade by NRSROs may be assigned a NAIC 1 or NAIC 2 designation based on the cost basis of the security relative to estimated recoverable amounts as determined by the NAIC. Refer to the table below for a summary of our fixed maturity securities, available for sale, by NAIC designations.

The NAIC evaluates the fixed maturity investments of insurers for regulatory and capital assessment purposes and assigns securities to one of six credit quality categories called NAIC designations, which are used by insurers when preparing their annual statements based on statutory accounting principles. The NAIC designations are generally similar to the credit quality designations of the NRSROs for marketable fixed maturity securities, except for certain structured securities. However, certain structured securities rated below investment grade by the NRSROs can be assigned NAIC 1 or NAIC 2 designations depending on the cost basis of the holding relative to estimated recoverable amounts as determined by the NAIC. The following summarizes the NAIC designations and NRSRO equivalent ratings:

|  |  |
| ---: | --- |
| NAIC Designation | NRSRO Equivalent Rating |
| 1 | AAA/AA/A |
| 2 | BBB |
| 3 | BB |
| 4 | B |
| 5 | CCC and lower |
| 6 | In or near default |

A summary of our fixed maturity securities, available for sale, by NAIC designations (or for fixed maturity securities held by non-regulated entities, based on NRSRO ratings) as of June 30, 2020 is as follows (dollars in millions):

| NAIC designation | Amortized cost | Estimated fair value | Percentage of total estimated fair value |
| ---: | ---: | ---: | ---: |
| 1 | $10,806.7 | $12,240.1 | 55.2% |
| 2 | 7,934.0 | 9,037.0 | 40.8 |
| Total NAIC 1 and 2 (investment grade) | 18,740.7 | 21,277.1 | 96.0 |
| 3 | 660.3 | 656.4 | 3.0 |
| 4 | 218.1 | 212.2 | .9 |
| 5 | 21.5 | 21.2 | .1 |
| 6 | 1.0 | 1.0 | — |
| Total NAIC 3, 4, 5 and 6 (below-investment grade) | 900.9 | 890.8 | 4.0 |
| Total | $19,641.6 | $22,167.9 | 100.0% |

80

#### Fixed Maturity Securities, Available for Sale

The following table summarizes the carrying values and gross unrealized losses of our fixed maturity securities, available for sale, by category as of June 30, 2020 (dollars in millions):

|  | Carrying value | Percent of fixed maturities | Gross unrealized losses | Percent of gross unrealized losses |
| --- | ---: | ---: | ---: | ---: |
| States and political subdivisions | $2,483.4 | 11.2% | $6.8 | 4.6% |
| Non-agency residential mortgage-backed securities | 2,138.2 | 9.7 | 10.6 | 7.0 |
| Commercial mortgage-backed securities | 1,893.6 | 8.5 | 46.9 | 31.0 |
| Banks | 1,582.8 | 7.1 | 5.8 | 3.8 |
| Utilities | 1,506.9 | 6.8 | 1.2 | .8 |
| Insurance | 1,479.7 | 6.7 | 6.5 | 4.3 |
| Healthcare/pharmaceuticals | 1,307.6 | 5.9 | 1.8 | 1.2 |
| Asset-backed securities | 1,175.4 | 5.3 | 23.9 | 15.8 |
| Food/beverage | 945.5 | 4.3 | .6 | .4 |
| Energy | 774.9 | 3.5 | 14.1 | 9.3 |
| Technology | 727.5 | 3.3 | .5 | .3 |
| Brokerage | 725.8 | 3.3 | 1.2 | .8 |
| Telecom | 576.1 | 2.6 | — | — |
| Transportation | 533.5 | 2.4 | .6 | .4 |
| Real estate/REITs | 468.9 | 2.1 | 3.0 | 2.0 |
| Cable/media | 451.3 | 2.0 | .4 | .3 |
| Collateralized loan obligations | 442.5 | 2.0 | 15.1 | 9.9 |
| Capital goods | 431.1 | 1.9 | .5 | .3 |
| Chemicals | 375.0 | 1.7 | 1.2 | .8 |
| U.S. Treasury and Obligations | 230.3 | 1.0 | — | — |
| Other | 1,917.9 | 8.7 | 10.6 | 7.0 |
| Total fixed maturities, available for sale | $22,167.9 | 100.0% | $151.3 | 100.0% |

#### Below-Investment Grade Securities

At June 30, 2020, the amortized cost of the Company's below-investment grade fixed maturity securities, available for sale, was $2,006.1 million, or 10 percent of the Company's fixed maturity portfolio. The estimated fair value of the below-investment grade portfolio was $2,098.1 million, or 105 percent of the amortized cost.

Below-investment grade corporate debt securities typically have different characteristics than investment grade corporate debt securities. Based on historical performance, probability of default by the borrower is significantly greater for below-investment grade corporate debt securities and in many cases severity of loss is relatively greater as such securities are generally unsecured and often subordinated to other indebtedness of the issuer. Also, issuers of below-investment grade corporate debt securities frequently have higher levels of debt relative to investment-grade issuers, hence, all other things being equal, are generally more sensitive to adverse economic conditions. The Company attempts to reduce the overall risk related to its investment in below-investment grade securities, as in all investments, through careful credit analysis, strict investment policy guidelines, and diversification by issuer and/or guarantor and by industry.

#### Net Realized and Unrealized Investment Losses

During the first six months of 2020, the $50.4 million of realized losses on sales of $402.4 million of fixed maturity securities, available for sale included: (i) $15.1 million related to various corporate securities; (ii) $25.0 million related to commercial mortgage-backed securities; and (iii) $10.3 million related to various other investments. Securities are generally sold at a loss following unforeseen issuer-specific events or conditions or shifts in perceived relative values. These reasons include but are not limited to: (i) changes in the investment environment, including changes in relative value among potential investment strategies; (ii) expectation that the market value could deteriorate; (iii) our desire to reduce our exposure to an asset class, an issuer or an industry; (iv) prospective or actual changes in credit quality; or (v) changes in expected portfolio cash flows.

During the first six months of 2019, the $52.3 million of realized losses on sales of $877.4 million of fixed maturity securities, available for sale, included: (i) $45.2 million related to various corporate securities; and (ii) $7.1 million related to various other investments.

The following summarizes the investments sold at a loss during the first six months of 2020 which had been continuously in an unrealized loss position exceeding 20 percent of the amortized cost basis prior to the sale for the period indicated (dollars in millions):

|  | Number of issuers | At date of sale Amortized cost | Fair value |
| --- | ---: | ---: | ---: |
| Less than 6 months prior to sale | 17 | $49.1 | $34.6 |
| Greater than or equal to 6 months and less than 12 months prior to sale | 1 | 3.1 | 1.9 |
| Total | 18 | $52.2 | $36.5 |

Prior to January 1, 2020, we regularly evaluated all of our investments with unrealized losses for possible impairment. Our assessment of whether unrealized losses were "other than temporary" required significant judgment. Factors considered included: (i) the extent to which fair value was less than the cost basis; (ii) the length of time that the fair value had been less than cost; (iii) whether the unrealized loss was event driven, credit-driven or a result of changes in market interest rates or risk premium; (iv) the near-term prospects for specific events, developments or circumstances likely to affect the value of the investment; (v) the investment's rating and whether the investment was investment-grade and/or had been downgraded since its purchase; (vi) whether the issuer was current on all payments in accordance with the contractual terms of the investment and was expected to meet all of its obligations under the terms of the investment; (vii) whether we intended to sell the investment or it was more likely than not that circumstances would require us to sell the investment before recovery occurs; (viii) the underlying current and prospective asset and enterprise values of the issuer and the extent to which the recoverability of the carrying value of our investment would be affected by changes in such values; (ix) projections of, and unfavorable changes in, cash flows on structured securities including mortgage-backed and asset-backed securities; (x) our best estimate of the value of any collateral; and (xi) other objective and subjective factors.

Future events may occur, or additional information may become available, which may necessitate future realized losses in our portfolio. Significant losses could have a material adverse effect on our consolidated financial statements in future periods.

The following table sets forth the amortized cost and estimated fair value of those fixed maturities, available for sale, with unrealized losses at June 30, 2020, by contractual maturity. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties. Structured securities frequently include provisions for periodic principal payments and permit periodic unscheduled payments.

*(Dollars in millions)*

|  | Amortized cost | Estimated fair value |
| --- | ---: | ---: |
| Due in one year or less | $2.4 | $2.5 |
| Due after one year through five years | 152.7 | 149.4 |
| Due after five years through ten years | 319.7 | 305.3 |
| Due after ten years | 712.3 | 664.6 |
| Subtotal | 1,187.1 | 1,121.8 |
| Structured securities | 2,094.7 | 1,997.9 |
| Total | $3,281.8 | $3,119.7 |

The following summarizes the investments in our portfolio rated below-investment grade not deemed to have credit losses which have been continuously in an unrealized loss position exceeding 20 percent of the cost basis for the period indicated as of June 30, 2020 (dollars in millions):

|  | Number of issuers | Cost basis | Unrealized loss | Estimated fair value |
| --- | ---: | ---: | ---: | ---: |
| Less than 6 months | 1 | $12.5 | $(3.6) | $8.9 |
| Total |  | $12.5 | $(3.6) | $8.9 |

83

The following table summarizes the gross unrealized losses of our fixed maturity securities, available for sale, by category and ratings category as of June 30, 2020 (dollars in millions):

|  | Investment grade AAA/AA/A | BBB | Below-investment grade BB | B+ and below | Total gross unrealized losses |
| --- | ---: | ---: | ---: | ---: | ---: |
| Commercial mortgage-backed securities | $39.5 | $4.0 | $3.4 | $— | $46.9 |
| Asset-backed securities | 6.1 | 12.1 | 3.8 | 1.9 | 23.9 |
| Collateralized loan obligations | 15.1 | — | — | — | 15.1 |
| Energy | — | 5.4 | 8.7 | — | 14.1 |
| Non-agency residential mortgage-backed securities | 1.3 | 1.4 | 5.3 | 2.6 | 10.6 |
| States and political subdivisions | .3 | 3.0 | 3.5 | — | 6.8 |
| Insurance | .1 | 6.3 | — | .1 | 6.5 |
| Banks | .7 | 5.0 | — | .1 | 5.8 |
| Real estate/REITs | 1.4 | 1.5 | .1 | — | 3.0 |
| Aerospace/defense | — | 2.8 | — | .1 | 2.9 |
| Retail | — | 2.2 | .4 | .1 | 2.7 |
| Entertainment/hotels | — | — | 2.3 | .1 | 2.4 |
| Healthcare/pharmaceuticals | — | 1.6 | .1 | .1 | 1.8 |
| Brokerage | .3 | .8 | .1 | — | 1.2 |
| Chemicals | — | 1.0 | .2 | — | 1.2 |
| Autos | — | 1.1 | — | .1 | 1.2 |
| Utilities | — | 1.2 | — | — | 1.2 |
| Other | .6 | 1.1 | 1.2 | 1.1 | 4.0 |
| Total fixed maturities, available for sale | $65.4 | $50.5 | $29.1 | $6.3 | $151.3 |

Our investment strategy is to maximize, over a sustained period and within acceptable parameters of quality and risk, investment income and total investment return through active strategic asset allocation and investment management. Accordingly, we may sell securities at a gain or a loss to enhance the projected total return of the portfolio as market opportunities change, to reflect changing perceptions of risk, or to better match certain characteristics of our investment portfolio with the corresponding characteristics of our insurance liabilities.

#### Structured Securities

At June 30, 2020, fixed maturity investments included structured securities with an estimated fair value of $5.7 billion (or 25.8 percent of all fixed maturity securities). The yield characteristics of structured securities generally differ in some respects from those of traditional corporate fixed-income securities or government securities. For example, interest and principal payments on structured securities may occur more frequently, often monthly. In many instances, we are subject to variability in the amount and timing of principal and interest payments. For example, in many cases, partial prepayments may occur at the option of the issuer and prepayment rates are influenced by a number of factors that cannot be predicted with certainty, including: the relative sensitivity of prepayments on the underlying assets backing the security to changes in interest rates and asset values; the availability of alternative financing; a variety of economic, geographic and other factors; the timing, pace and proceeds of liquidations of defaulted collateral; and various security-specific structural considerations (for example, the repayment priority of a given security in a securitization structure). In addition, the total amount of payments for non-agency structured securities may be affected by changes to cumulative default rates or loss severities of the related collateral.

The amortized cost and estimated fair value of structured securities at June 30, 2020, summarized by type of security, were as follows (dollars in millions):

| Type | Amortized cost | Estimated fair value Amount | Percent of fixed maturities |
| --- | ---: | ---: | ---: |
| Asset-backed securities | $1,172.4 | $1,175.4 | 5.3% |
| Agency residential mortgage-backed securities | 67.8 | 75.4 | .3 |
| Non-agency residential mortgage-backed securities | 2,000.3 | 2,138.2 | 9.7 |
| Commercial mortgage-backed securities | 1,881.0 | 1,893.6 | 8.5 |
| Collateralized loan obligations | 457.6 | 442.5 | 2.0 |
| Total structured securities | $5,579.1 | $5,725.1 | 25.8% |

Residential mortgage-backed securities ("RMBS") include transactions collateralized by agency-guaranteed and non-agency mortgage obligations. Non-agency RMBS investments are primarily categorized by underlying borrower credit quality: Prime, Alt-A, Non-Qualified Mortgage ("Non-QM"), and Subprime. Prime borrowers typically default with the lowest frequency, Alt-A and Non-QM default at higher rates, and Subprime borrowers default with the highest frequency. In addition to borrower credit categories, RMBS investments include Re-Performing Loan ("RPL") and Credit Risk Transfer ("CRT") transactions. RPL transactions include borrowers with prior difficulty meeting the original mortgage terms and were subsequently modified, resulting in a sustainable payback arrangement. CRT securities are collateralized by Government-Sponsored Enterprise ("GSE") conforming mortgages and Prime borrowers, but without an agency guarantee against default losses.

Commercial mortgage-backed securities ("CMBS") are secured by commercial real estate mortgages, generally income producing properties that are managed for profit. Property types include multi-family dwellings including apartments, retail centers, hotels, restaurants, hospitals, nursing homes, warehouses, and office buildings. While most CMBS have call protection features whereby underlying borrowers may not prepay their mortgages for stated periods of time without incurring prepayment penalties, recoveries on defaulted collateral may result in involuntary prepayments.

### INVESTMENTS IN VARIABLE INTEREST ENTITIES

The following table provides supplemental information about the revenues and expenses of the VIEs which have been consolidated in accordance with authoritative guidance, after giving effect to the elimination of our investment in the VIEs and investment management fees earned by a subsidiary of the Company (dollars in millions):

| Revenues: | Three months ended June 30, 2020 | 2019 | Six months ended June 30, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| Net investment income – policyholder and other special-purpose portfolios | $13.0 | $18.6 | $28.3 | $40.8 |
| Fee revenue and other income | 1.3 | 1.5 | 2.6 | 3.1 |
| Total revenues | 14.3 | 20.1 | 30.9 | 43.9 |
| Expenses: |  |  |  |  |
| Interest expense | 9.0 | 13.7 | 19.7 | 30.2 |
| Other operating expenses | .4 | .8 | .7 | 1.2 |
| Total expenses | 9.4 | 14.5 | 20.4 | 31.4 |
| Income before net realized investment gains (losses) and income taxes | 4.9 | 5.6 | 10.5 | 12.5 |
| Net realized investment gains (losses) | 8.8 | (6.3) | (21.3) | (14.5) |
| Income (loss) before income taxes | $13.7 | $(.7) | $(10.8) | $(2.0) |

86

#### Supplemental Information on Investments Held by VIEs

The following table summarizes the carrying values of the investments held by the VIEs by category as of June 30, 2020 (dollars in millions):

|  | Carrying value | Percent of fixed maturities | Gross unrealized losses | Percent of gross unrealized losses |
| --- | ---: | ---: | ---: | ---: |
| Healthcare/pharmaceuticals | $143.7 | 12.6% | $7.6 | 12.8% |
| Technology | 126.6 | 11.1 | 4.9 | 8.1 |
| Cable/media | 117.8 | 10.3 | 5.3 | 8.9 |
| Food/beverage | 81.1 | 7.1 | 4.5 | 7.6 |
| Capital goods | 71.7 | 6.3 | 3.7 | 6.2 |
| Consumer products | 53.7 | 4.7 | 4.0 | 6.8 |
| Aerospace/defense | 51.2 | 4.5 | 2.8 | 4.6 |
| Building materials | 48.7 | 4.3 | 2.0 | 3.4 |
| Brokerage | 48.4 | 4.3 | 1.6 | 2.6 |
| Paper | 46.7 | 4.1 | 2.3 | 3.8 |
| Chemicals | 37.1 | 3.3 | 1.6 | 2.7 |
| Transportation | 32.1 | 2.8 | 1.9 | 3.2 |
| Autos | 31.5 | 2.8 | 2.0 | 3.3 |
| Utilities | 29.8 | 2.6 | 1.2 | 2.0 |
| Retail | 28.9 | 2.5 | 2.2 | 3.8 |
| Insurance | 28.4 | 2.5 | 1.0 | 1.7 |
| Gaming | 26.5 | 2.3 | 1.6 | 2.7 |
| Business services | 18.1 | 1.6 | 1.0 | 1.6 |
| Metals and mining | 12.1 | 1.1 | .6 | 1.0 |
| Entertainment/hotels | 11.5 | 1.0 | 1.3 | 2.2 |
| Other | 91.8 | 8.2 | 6.6 | 11.0 |
| Total | $1,137.4 | 100.0% | $59.7 | 100.0% |

87

The following table sets forth the amortized cost and estimated fair value of those investments held by the VIEs with unrealized losses at June 30, 2020, by contractual maturity. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.

*(Dollars in millions)*

|  | Amortized cost | Estimated fair value |
| --- | ---: | ---: |
| Due in one year or less | $1.0 | $.4 |
| Due after one year through five years | 753.7 | 691.6 |
| Due after five years through ten years | 429.0 | 404.6 |
| Due after ten years | 4.0 | 3.7 |
| Total | $1,187.7 | $1,100.3 |

The following summarizes the investments sold at a loss during the first six months of 2020 which had been continuously in an unrealized loss position exceeding 20 percent of the amortized cost basis prior to the sale for the period indicated (dollars in millions):

|  | Number of issuers | At date of sale Amortized cost | Fair value |
| --- | ---: | ---: | ---: |
| Less than 6 months prior to sale | 4 | $5.9 | $4.0 |
|  | 4 | $5.9 | $4.0 |

The following summarizes the investments in our portfolio rated below-investment grade not deemed to have credit losses which have been continuously in an unrealized loss position exceeding 20 percent of the cost basis for the period indicated as of June 30, 2020 (dollars in millions):

|  | Number of issuers | Cost basis | Unrealized loss | Estimated fair value |
| --- | ---: | ---: | --- | ---: |
| Less than 6 months | 1 | $3.5 | $(.9) | $2.6 |
|  |  | $3.5 | $(.9) | $2.6 |

### NEW ACCOUNTING STANDARDS

See "Recently Issued Accounting Standards" in the notes to consolidated financial statements for a discussion of recently issued accounting standards.

## Market risk

As filed, 535 characters.

Our market risks, and the ways we manage them, are summarized in "Management's Discussion and Analysis of Financial Condition and Results of Operations", included in our Annual Report on Form 10-K for the year ended December 31, 2019. For additional information and risks related to the impact of the COVID-19 pandemic refer to Liquidity and Capital Resources - Potential Impacts of COVID-19 Pandemic included in Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations and Item 1A - Risk Factors.

## Controls and procedures

As filed, 1,446 characters.

*Evaluation of Disclosure Controls and Procedures.* CNO's management, under the supervision and with the participation of the Chief Executive Officer and the Chief Financial Officer, evaluated the effectiveness of CNO's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended). Based on its evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of June 30, 2020, CNO's disclosure controls and procedures were effective to ensure that information required to be disclosed by CNO in reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures are also designed to reasonably assure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

*Changes to Internal Control Over Financial Reporting.* There were no changes in the Company's internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934) during the three months ended June 30, 2020, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 18,437 characters.

CNO and its businesses are subject to a number of risks including general business and financial risk factors. Any or all of such factors could have a material adverse effect on the business, financial condition or results of operations of CNO. Refer to "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2019, for further discussion of such risk factors. There have been no material changes from such previously disclosed risk factors other than those included below:

***The COVID-19 pandemic has adversely impacted our business, and the ultimate effect on our business, results of operations and financial condition will depend on future developments that are highly uncertain, including the scope and duration of the pandemic and actions taken by governmental authorities in response to the pandemic.***

The COVID-19 pandemic has negatively impacted the U.S. and global economy, created significant volatility and disruption in the capital markets, dramatically increased unemployment levels and has fueled concerns that it will lead to a global recession. In addition, the pandemic has resulted in temporary, and in some cases permanent, closures of many businesses and schools and the institution of social distancing and sheltering in place requirements in many states and local communities. As a result, our ability to sell products through our regular channels and the demand for our products and services has been significantly impacted. In the second quarter of 2020, our sales of health and life insurance products (measured by new annualized premiums) decreased by 19 percent compared to the same period in 2019. In addition, premiums collected on annuity products decreased 29 percent in the second quarter of 2020 compared to the same period in 2019. The extent to which the COVID-19 pandemic impacts our business, results of operations or financial condition will depend on the effectiveness of the measures already in place and actions taken, as well as on future developments which are highly uncertain and cannot be predicted, including the scope and duration of the pandemic and actions taken by governmental authorities and other third parties in response to the pandemic, and could continue to cause us to revise financial targets or other guidance we have previously provided.

While we have implemented risk management and contingency plans and taken other precautions with respect to the COVID-19 pandemic, such measures may not adequately protect our business from the full impacts of the pandemic. Currently, most of our employees are working remotely with only a few operationally critical employees working at certain of our facilities for business continuity purposes. An extended period of remote work arrangements could strain our business continuity plans, introduce additional operational risk, including but not limited to cybersecurity risks, and impair our ability to effectively manage our business. The frequency and sophistication of attempts at unauthorized access to our technology systems and fraud may increase, and COVID-19 pandemic conditions may impair our cybersecurity efforts and risk management. We also outsource a variety of functions to third parties, including certain of our administrative operations. As a result, we rely upon the successful implementation and execution of the business continuity planning of such entities in the current environment. While we closely monitor the business continuity activities of these third parties, successful implementation and execution of their business continuity strategies are largely outside our control. If one or more of the third parties to whom we outsource certain critical business activities experience operational failures, or is otherwise unable to perform, as a result of the impacts from the spread of COVID-19 and governmental reactions thereto, it could adversely impact our business, results of operations or financial condition.

We expect higher claims on our life and certain health insurance products due to the COVID-19 pandemic which would unfavorably impact our results of operations. In the second quarter of 2020, our margin on life insurance products reflects an estimated $14 million adverse mortality impact related to COVID-19. We expect COVID-19 to continue to adversely impact our life insurance margin in future quarters. In addition, economic uncertainty and unemployment resulting from the impacts of the spread of COVID-19 and governmental reactions thereto may also result in policyholders seeking sources of liquidity and withdrawing at rates greater than we previously expected. In addition, many state insurance departments are requiring insurers to offer flexible premium payment plans, relax payment dates, waive late fees and penalties in order to avoid canceling or non- renewing polices. If policyholder lapse and surrender rates or premium waivers significantly exceed our expectations, we may need to change our assumptions, models or reserves. The cost of reinsurance to us for these policies could increase, and we may encounter decreased availability of such reinsurance. Each of these could have a material adverse effect on our business, financial condition, results of operations, liquidity and cash flows. Such events or conditions could also have an adverse effect on product sales.

Our investment portfolio (specifically, the increased risk of defaults, downgrades, volatility in the valuations of certain investment assets we hold and lowered variable investment income and returns) has been, and may continue to be, adversely affected as a result the COVID-19 pandemic and uncertainty regarding its outcome. Moreover, volatility in equity markets and sustained lower interest rates, reduced liquidity or a continued slowdown in the United States or in global economic conditions may also adversely affect the values and cash flows of these assets. Our investments in mortgages and commercial mortgage-backed securities have been, and could continue to be, negatively affected by delays or failures of borrowers to make payments of principal and interest when due or delays or moratoriums on foreclosures, enforcement actions with respect to delinquent or defaulted mortgages imposed by governmental authorities or the failure of tenants to pay rent or tenants' demands for lease modifications. Further, severe market volatility may leave us unable to react to market events in a prudent manner consistent with our historical investment practices. Market dislocations, decreases in observable market activity or unavailability of information, in each case, arising from the spread of COVID-19, may restrict our access to key inputs used to derive certain estimates and assumptions made in connection with financial reporting or otherwise. Restricted access to such inputs may make our financial statement balances and estimates and assumptions used to run our business subject to greater variability and subjectivity.

Additionally, COVID-19 could negatively affect our internal controls over financial reporting as the vast majority of our employees are required to work from home and onsite locations remain closed, and therefore new processes, procedures, and controls could be required to respond to changes in our business environment. Further, should any key employees become ill from COVID-19 and unable to work, our ability to operate our internal controls may be adversely impacted.

Any of the direct or indirect effects of the COVID-19 pandemic may cause litigation or regulatory, investor, media, or public inquiries. We may face increased workplace safety costs and risks, lose access to critical employees, and face increased employment-related claims and employee-relations challenges, each of which may increase when our employees begin to return to our workplaces. Our costs to manage and effectively respond to these matters, and to address them in settlement or other ways, may increase.

Any uncertainty as a result of any of these events may require us to change our estimates, assumptions, models or reserves. Refer to "Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations - Changes in Actuarial Assumptions in the Second Quarter of 2020" for further information related to changes in certain actuarial assumptions and their impact on our operating results in the second quarter of 2020. Authorities may not accurately report population and impact data, such as death rates, infections, morbidity, hospitalizations, or illness that we use in our estimates, assumptions and models. Further, the speed at which these events are occurring increases the uncertainty of our estimates, assumptions and models. Any of these events could cause or contribute to the risks and uncertainties enumerated in our Annual Report on Form 10-K and could materially adversely affect our business, results of operations or financial condition. For additional forward-looking information and risks related to the impact of the pandemic, refer to Liquidity and Capital Resources - Potential Impacts of COVID-19 Pandemic included in Management's Discussion and Analysis of Financial Condition and Results of Operations.

***Potential continuation of a low interest rate environment for an extended period of time may negatively impact our results of operations, financial position and cash flows.***

In recent periods, interest rates have been at or near historically low levels. Some of our products, principally traditional whole life, universal life, fixed rate and fixed index annuity contracts, expose us to the risk that low or declining interest rates will reduce our spread (the difference between the amounts that we are required to pay under the contracts and the investment income we are able to earn on the investments supporting our obligations under the contracts). Our spread is a key component of our net income. Investment income is also an important component of the profitability of our health products, especially long-term care and supplemental health policies. In addition, interest rates impact the liability for the benefits we provide under our agent deferred compensation plan (as it is our policy to immediately recognize changes in assumptions used to determine this liability).

If interest rates were to decrease further or remain at low levels for an extended period of time, we may have to invest new cash flows or reinvest proceeds from investments that have matured or have been prepaid or sold at yields that have the effect of reducing our net investment income as well as the spread between interest earned on investments and interest credited to some of our products below present or planned levels. To the extent prepayment rates on fixed maturity investments or mortgage loans in our investment portfolio exceed our assumptions, this could increase the impact of this risk. We can lower crediting rates on certain products to offset the decrease in investment yield. However, our ability to lower these rates may be limited by: (i) contractually guaranteed minimum rates; or (ii) competition. In addition, a decrease in crediting rates may not match the timing or magnitude of changes in investment yields. Currently, the vast majority of our products with contractually guaranteed minimum rates have crediting rates set at the minimum rate. As a result, further decreases in investment yields would decrease the spread we earn and such spread could potentially become a loss.

The following table summarizes the distribution of annuity and universal life account values, net of amounts ceded, by guaranteed interest crediting rates as of December 31, 2019 (dollars in millions):

| Guaranteed rate | Fixed index annuities | Fixed interest annuities | Universal life | Total |
| --- | ---: | ---: | ---: | ---: |
| \> 5.0% to 6.0% | $— | $.3 | $9.4 | $9.7 |
| \> 4.0% to 5.0% | — | 27.0 | 263.9 | 290.9 |
| \> 3.0% to 4.0% | 15.7 | 715.8 | 42.0 | 773.5 |
| \> 2.0% to 3.0% | 703.6 | 819.2 | 229.3 | 1,752.1 |
| \> 1.0% to 2.0% | 1,666.7 | 237.4 | 27.6 | 1,931.7 |
| 1.0% and under | 4,749.2 | 423.5 | 453.2 | 5,625.9 |
|  | $7,135.2 | $2,223.2 | $1,025.4 | $10,383.8 |
| Weighted average | 1.24% | 2.73% | 2.55% | 1.69% |

At December 31, 2019, $1.7 billion and $.3 billion of our fixed interest annuity and universal life account values, respectively, net of amounts ceded, were at minimum guaranteed crediting rates. The weighted average crediting rates at December 31, 2019, related to such annuity and universal life account values, that were at the minimum guaranteed crediting rate were 1.86 percent and 1.67 percent, respectively.

Our fixed index annuity products provide a guaranteed minimum rate of return and a higher potential return that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the Standard & Poor's 500 Index, over a specified period. We are generally able to change the participation rate at the beginning of each index period (typically on each policy anniversary date), subject to contractual minimums. At December 31, 2019, $.7 billion of our fixed index annuity account values were at contractual minimum guarantees or participation rates.

During periods of declining or low interest rates, life and annuity products may be relatively more attractive to consumers, resulting in increased premium payments on products with flexible premium features, repayment of policy loans and increased persistency (a higher percentage of insurance policies remaining in force from year-to-year).

Our expectation of future investment income is an important consideration in determining the amortization of insurance acquisition costs and analyzing the recovery of these assets as well as determining the adequacy of our liabilities for insurance products. Expectations of lower future investment earnings may cause us to accelerate amortization, write down the balance of insurance acquisition costs or establish additional liabilities for insurance products, thereby reducing net income in the future periods.

In the fourth quarter of 2019, we completed a comprehensive review of interest rate assumptions on all of our products which were updated to reflect the projected returns on our investment portfolio. The new money rate is the rate of return we receive on cash flows invested at a current date. If new money rates are lower than the overall weighted average return we earn from our investment portfolio, and the lower rates persist, our overall earned rates will decrease. Specifically, our current projections assume new money rates ranging from 3.65 percent to 4.85 percent for one year (previously ranged from 4.65 percent to 5.67 percent) and then grade over 5 years from these levels to an ultimate new money rate ranging from 4.98 percent to 5.75 percent (previously ranged from 5.23 percent to 6.00 percent), depending on the specific product.

In the second quarter of 2020, we updated our new money rate assumptions given our expectation that interest rates will remain low for the long-term. Specifically, our current projections assume new money rates ranging from 3.65 percent to 4.85 percent forever. The overall average new money rate assumed is 4 percent. The change in this assumption had the following impacts: (i) the change in the new money rate and related impact to persistency assumptions had a $45.6 million unfavorable impact on pre-tax earnings in the second quarter of 2020; (ii) the change in future option costs we incur in providing benefits on fixed index annuities had a favorable impact on pre-tax earnings of $91.5 million; and (iii) the future margins in our insurance block would be reduced by approximately $280 million ($120 million for interest-sensitive life and annuity products and $160 million for all non-interest sensitive products). Refer to "Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations - Changes in Actuarial Assumptions in the Second Quarter of 2020" for further information related to the change in assumptions in the second quarter of 2020.

The following hypothetical scenarios illustrate the sensitivity of changes in interest rates to our products (based on our 2019 comprehensive actuarial review):

- The first hypothetical scenario assumes immediate and permanent reductions to current interest rate spreads on interest-sensitive products. We estimate that a pre-tax charge of approximately $30 million would occur if we increased credited rates related to our interest-sensitive life and annuity products immediately and permanently by 10 basis points due to an increase in the rate credited to account values (or an equivalent increase to the amount allocated to the cost of options for our fixed index annuity products) with no change to assumed earned rates.
- The second scenario assumes that new money rates decrease approximately 100 basis points and remain at that level indefinitely on non-interest sensitive products. We estimate that this scenario would not result in a pre-tax charge but would reduce future margins on non-interest sensitive products by approximately $210 million.
- The third scenario assumes that new money rates decrease approximately 200 basis points and remain at that level indefinitely on non-interest sensitive products. We estimate that this scenario would not result in a pre-tax charge but would reduce future margins on non-interest sensitive products by approximately $420 million.

Although the hypothetical revisions described in the scenarios summarized above are not currently required or anticipated, we believe similar changes could occur based on past variances in experience and our expectations of the ranges of future experience that could reasonably occur. We have assumed that revisions to assumptions resulting in such adjustments would occur equally among policy types, ages and durations within each product classification. Any actual adjustment would be dependent on the specific policies affected and, therefore, may differ from such estimates. In addition, the impact of actual adjustments would reflect the net effect of all changes in assumptions during the period.

Sustained periods of low or declining interest rates may adversely affect our results of operations, financial position and cash flows.

Filed Aug 7, 2020.
Source: SEC EDGAR, the filing index for accession 0001224608-20-000032. Last ingested by Listed: Nov 14, 2026, 19:45 ET. No prices; not investment advice.
